{"data":[{"attr_val":"3124","sample":"TCGA-OR-A5J2-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5J2-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5J2-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"46B7EB7C-E5F7-476D-A68C-5972F947445F","sample":"TCGA-OR-A5J2-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5J2-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"1584","sample":"TCGA-OR-A5J3-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5J3-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5J3-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"1FB59B6F-53C0-4B14-82CC-77CD55C67AD6","sample":"TCGA-OR-A5J3-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5J3-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"4642","sample":"TCGA-OR-A5J4-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5J4-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5J4-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"51EE1274-9144-4464-AA1E-AD15D9086984","sample":"TCGA-OR-A5J4-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5J4-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"4537","sample":"TCGA-OR-A5J5-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5J5-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5J5-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"C6214F9B-35C8-424C-B6FE-BEC1A9317C0A","sample":"TCGA-OR-A5J5-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5J5-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"2220","sample":"TCGA-OR-A5J6-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5J6-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5J6-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"C0C9DD1B-98B1-4A20-8927-3C0B75A4559E","sample":"TCGA-OR-A5J6-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5J6-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"1388","sample":"TCGA-OR-A5J7-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5J7-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5J7-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"945CC9B8-A732-484E-B423-9EFBC556E3FD","sample":"TCGA-OR-A5J7-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5J7-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"396","sample":"TCGA-OR-A5J8-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5J8-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5J8-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"2F47F06E-8F76-440E-BBCE-B7C90635A59E","sample":"TCGA-OR-A5J8-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5J8-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"849","sample":"TCGA-OR-A5J9-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5J9-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5J9-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"14D95372-5444-4525-B2D6-19FC51F3E336","sample":"TCGA-OR-A5J9-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5J9-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"2931","sample":"TCGA-OR-A5JA-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5JA-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5JA-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"292BCBE1-2FB7-4781-89DA-C33F4589E71B","sample":"TCGA-OR-A5JA-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5JA-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"4678","sample":"TCGA-OR-A5JB-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5JB-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5JB-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"0C98B45D-09A6-48A6-89BA-48BA7A2142D5","sample":"TCGA-OR-A5JB-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5JB-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"4331","sample":"TCGA-OR-A5JC-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5JC-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5JC-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"01C1AD9E-B440-4394-942F-6128CFCB77CF","sample":"TCGA-OR-A5JC-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5JC-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"1908","sample":"TCGA-OR-A5JF-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5JF-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5JF-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"90F61EDA-6C83-48BA-87E0-2FE89BBFF03E","sample":"TCGA-OR-A5JF-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5JF-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"1771","sample":"TCGA-OR-A5JG-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5JG-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5JG-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"6D3146BA-8068-4DA5-BAAF-33C6946F138F","sample":"TCGA-OR-A5JG-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5JG-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"1499","sample":"TCGA-OR-A5JI-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5JI-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5JI-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"24C2E7DC-0162-4012-8ADD-A252FF535F9C","sample":"TCGA-OR-A5JI-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5JI-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"1308","sample":"TCGA-OR-A5JJ-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5JJ-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5JJ-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"0BE64816-8299-49B2-B96C-CD0F4DA7D37B","sample":"TCGA-OR-A5JJ-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5JJ-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"1301","sample":"TCGA-OR-A5JK-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5JK-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5JK-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"6EEBC241-9E55-4520-BB4E-73E20D25726B","sample":"TCGA-OR-A5JK-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5JK-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"1224","sample":"TCGA-OR-A5JL-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5JL-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5JL-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"91FA4F80-0838-4A7B-9943-35221D440E9D","sample":"TCGA-OR-A5JL-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5JL-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"657","sample":"TCGA-OR-A5JM-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5JM-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5JM-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"9D9ED7F5-8811-4EAD-A43D-52EF748B95B3","sample":"TCGA-OR-A5JM-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5JM-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"2773","sample":"TCGA-OR-A5JO-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5JO-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5JO-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"2D1788C4-196F-48C3-B0EC-E3F8DE351607","sample":"TCGA-OR-A5JO-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5JO-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"2520","sample":"TCGA-OR-A5JQ-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5JQ-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5JQ-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"98650D6C-1EAE-4A75-9AFC-7785229E1D99","sample":"TCGA-OR-A5JQ-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5JQ-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"3751","sample":"TCGA-OR-A5JR-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5JR-01","attr_id":"IS_FFPE"},{"attr_val":"false","sample":"TCGA-OR-A5JR-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"EC87C3B6-2C8B-4C01-BAAA-9E6F01F44AC1","sample":"TCGA-OR-A5JR-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5JR-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"699","sample":"TCGA-OR-A5JS-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5JS-01","attr_id":"IS_FFPE"},{"attr_val":"false","sample":"TCGA-OR-A5JS-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"693578FD-91D0-447E-BA98-DCAABEC8B4DB","sample":"TCGA-OR-A5JS-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5JS-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"419","sample":"TCGA-OR-A5JT-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5JT-01","attr_id":"IS_FFPE"},{"attr_val":"false","sample":"TCGA-OR-A5JT-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"EBED7059-064A-4785-A6DD-A8C29486FE7A","sample":"TCGA-OR-A5JT-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5JT-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"1696","sample":"TCGA-OR-A5JV-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5JV-01","attr_id":"IS_FFPE"},{"attr_val":"false","sample":"TCGA-OR-A5JV-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"19B13418-64A4-438B-8BA6-2B04F11FC9A5","sample":"TCGA-OR-A5JV-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5JV-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"1713","sample":"TCGA-OR-A5JW-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5JW-01","attr_id":"IS_FFPE"},{"attr_val":"false","sample":"TCGA-OR-A5JW-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"314F45AF-668C-4E36-9290-F8661B9258C7","sample":"TCGA-OR-A5JW-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5JW-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"1162","sample":"TCGA-OR-A5JX-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5JX-01","attr_id":"IS_FFPE"},{"attr_val":"false","sample":"TCGA-OR-A5JX-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"F7FD9793-2825-44F4-B265-FAE7178AE49F","sample":"TCGA-OR-A5JX-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5JX-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"414","sample":"TCGA-OR-A5JY-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5JY-01","attr_id":"IS_FFPE"},{"attr_val":"false","sample":"TCGA-OR-A5JY-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"2C8D4883-588E-441E-B20C-6208346D1F23","sample":"TCGA-OR-A5JY-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5JY-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"373","sample":"TCGA-OR-A5JZ-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5JZ-01","attr_id":"IS_FFPE"},{"attr_val":"false","sample":"TCGA-OR-A5JZ-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"83437041-D9DD-45A6-A0AC-17307FFB9513","sample":"TCGA-OR-A5JZ-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5JZ-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"1097","sample":"TCGA-OR-A5K0-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5K0-01","attr_id":"IS_FFPE"},{"attr_val":"false","sample":"TCGA-OR-A5K0-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"1E6B9FC4-3FED-4D32-89B8-AA15FB4A5840","sample":"TCGA-OR-A5K0-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5K0-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"2513","sample":"TCGA-OR-A5K1-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5K1-01","attr_id":"IS_FFPE"},{"attr_val":"false","sample":"TCGA-OR-A5K1-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"C5F36CF1-4C1D-4633-BD0A-5E7F47CE7374","sample":"TCGA-OR-A5K1-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5K1-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"810","sample":"TCGA-OR-A5K2-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5K2-01","attr_id":"IS_FFPE"},{"attr_val":"false","sample":"TCGA-OR-A5K2-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"9DDAA508-3D15-4751-AB0F-69E4D8218FB3","sample":"TCGA-OR-A5K2-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5K2-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"2646","sample":"TCGA-OR-A5K3-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5K3-01","attr_id":"IS_FFPE"},{"attr_val":"false","sample":"TCGA-OR-A5K3-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"0727128A-84D8-47B9-A5F3-1F1EFF18F185","sample":"TCGA-OR-A5K3-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5K3-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"362","sample":"TCGA-OR-A5K4-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5K4-01","attr_id":"IS_FFPE"},{"attr_val":"false","sample":"TCGA-OR-A5K4-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"D35F621F-8426-43E7-B1BF-F670E46C7FA6","sample":"TCGA-OR-A5K4-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5K4-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"34","sample":"TCGA-OR-A5K5-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5K5-01","attr_id":"IS_FFPE"},{"attr_val":"false","sample":"TCGA-OR-A5K5-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"5101736C-1FF9-40D4-A57D-5B660C2B4D1F","sample":"TCGA-OR-A5K5-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5K5-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"946","sample":"TCGA-OR-A5K6-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5K6-01","attr_id":"IS_FFPE"},{"attr_val":"false","sample":"TCGA-OR-A5K6-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"61884223-9CC2-4C14-8A73-6E1B6FBA3670","sample":"TCGA-OR-A5K6-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5K6-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"3864","sample":"TCGA-OR-A5K9-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5K9-01","attr_id":"IS_FFPE"},{"attr_val":"false","sample":"TCGA-OR-A5K9-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"E78F3AC4-0E3A-4DF8-873A-B7AB384CAF62","sample":"TCGA-OR-A5K9-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5K9-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"1120","sample":"TCGA-OR-A5KO-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5KO-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5KO-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"1F0390FB-B267-43A2-BA5C-5BB41850E3F8","sample":"TCGA-OR-A5KO-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5KO-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"2399","sample":"TCGA-OR-A5KT-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5KT-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5KT-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"92522F10-7730-4B1C-8916-428E86DA1D4F","sample":"TCGA-OR-A5KT-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5KT-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"4543","sample":"TCGA-OR-A5KU-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5KU-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5KU-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"EFBCD3A5-723A-4361-9769-C01336F5F22D","sample":"TCGA-OR-A5KU-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5KU-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"3429","sample":"TCGA-OR-A5KV-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5KV-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5KV-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"76F9ABF7-01AB-48BE-A7BB-23ADDDBCACF8","sample":"TCGA-OR-A5KV-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5KV-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"1245","sample":"TCGA-OR-A5KW-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5KW-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5KW-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"0A8E38A4-7E21-4A7A-A0D4-47455F1DB4CF","sample":"TCGA-OR-A5KW-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5KW-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"914","sample":"TCGA-OR-A5KX-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5KX-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5KX-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"57C08142-B394-49CB-A613-910A2264514E","sample":"TCGA-OR-A5KX-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5KX-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"939","sample":"TCGA-OR-A5KY-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5KY-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5KY-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"FF35CA1E-064F-4C89-9BBE-01D26C5C57BF","sample":"TCGA-OR-A5KY-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5KY-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"319","sample":"TCGA-OR-A5KZ-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5KZ-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5KZ-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"0C9C6928-BA38-49DA-A5CF-67DD8E038F60","sample":"TCGA-OR-A5KZ-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5KZ-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"4591","sample":"TCGA-OR-A5L3-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5L3-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5L3-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"FC7AA029-F103-41FB-ADD3-DD6070A13DAF","sample":"TCGA-OR-A5L3-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5L3-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"828","sample":"TCGA-OR-A5L5-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5L5-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5L5-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"321A91CE-7CC6-49E0-9E50-130DB43DB7F5","sample":"TCGA-OR-A5L5-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5L5-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"433","sample":"TCGA-OR-A5L6-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5L6-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5L6-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"0F19F2D5-D552-4F7A-88D8-BB559CB1CD0F","sample":"TCGA-OR-A5L6-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5L6-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"558","sample":"TCGA-OR-A5L8-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5L8-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5L8-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"EBFAAAE3-9A83-498D-AA97-7CF19208D2DA","sample":"TCGA-OR-A5L8-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5L8-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"2096","sample":"TCGA-OR-A5LK-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5LK-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5LK-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"FE5D3E56-2D21-49FD-8818-68E8FB24E51B","sample":"TCGA-OR-A5LK-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5LK-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"1790","sample":"TCGA-OR-A5LN-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5LN-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5LN-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"3A56DF78-5E32-4E8A-9B69-23CB8F781368","sample":"TCGA-OR-A5LN-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5LN-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"577","sample":"TCGA-OU-A5PI-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OU-A5PI-01","attr_id":"IS_FFPE"},{"attr_val":"false","sample":"TCGA-OU-A5PI-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"7BBF0A45-A675-4F05-AC45-9E92BA55D542","sample":"TCGA-OU-A5PI-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OU-A5PI-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"3025","sample":"TCGA-PK-A5H8-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-PK-A5H8-01","attr_id":"IS_FFPE"},{"attr_val":"false","sample":"TCGA-PK-A5H8-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"8E86E6C3-10D0-423B-9448-01567222E202","sample":"TCGA-PK-A5H8-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-PK-A5H8-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"92","sample":"TCGA-PK-A5H9-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-PK-A5H9-01","attr_id":"IS_FFPE"},{"attr_val":"false","sample":"TCGA-PK-A5H9-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"0A0A8E16-D3AF-4E98-802E-761966588E4F","sample":"TCGA-PK-A5H9-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-PK-A5H9-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"701","sample":"TCGA-PK-A5HA-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-PK-A5HA-01","attr_id":"IS_FFPE"},{"attr_val":"false","sample":"TCGA-PK-A5HA-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"1729D2D8-5722-4579-950C-55B14167C9FD","sample":"TCGA-PK-A5HA-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-PK-A5HA-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"3385","sample":"TCGA-PK-A5HB-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-PK-A5HB-01","attr_id":"IS_FFPE"},{"attr_val":"false","sample":"TCGA-PK-A5HB-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"C69DA3BD-BCDA-4627-B13A-AAE53EAB80FB","sample":"TCGA-PK-A5HB-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-PK-A5HB-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"1811","sample":"TCGA-OR-A5JH-01","attr_id":"DAYS_TO_COLLECTION"},{"attr_val":"NO","sample":"TCGA-OR-A5JH-01","attr_id":"IS_FFPE"},{"attr_val":"true","sample":"TCGA-OR-A5JH-01","attr_id":"OCT_EMBEDDED"},{"attr_val":"5DFDD66B-E079-4B5A-959E-A5558836D2F7","sample":"TCGA-OR-A5JH-01","attr_id":"OTHER_SAMPLE_ID"},{"attr_val":"Primary Tumor","sample":"TCGA-OR-A5JH-01","attr_id":"SAMPLE_TYPE"},{"attr_val":"44","sample":"TCGA-OR-A5J2-01","attr_id":"AGE"},{"attr_val":"Stage IV","sample":"TCGA-OR-A5J2-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Present","sample":"TCGA-OR-A5J2-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M1","sample":"TCGA-OR-A5J2-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5J2-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5J2-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"-16090","sample":"TCGA-OR-A5J2-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"1677","sample":"TCGA-OR-A5J2-01","attr_id":"DAYS_TO_DEATH"},{"attr_val":"0","sample":"TCGA-OR-A5J2-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5J2-01","attr_id":"DFS_MONTHS"},{"attr_val":"NA","sample":"TCGA-OR-A5J2-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Present","sample":"TCGA-OR-A5J2-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"HISPANIC OR LATINO","sample":"TCGA-OR-A5J2-01","attr_id":"ETHNICITY"},{"attr_val":"2013-12-3","sample":"TCGA-OR-A5J2-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5J2-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5J2-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Androgen","sample":"TCGA-OR-A5J2-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5J2-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5J2-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5J2-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5J2-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5J2-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5J2-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5J2-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2004","sample":"TCGA-OR-A5J2-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"350","sample":"TCGA-OR-A5J2-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5J2-01","attr_id":"LATERALITY"},{"attr_val":"1","sample":"TCGA-OR-A5J2-01","attr_id":"LYMPH_NODES_EXAMINED"},{"attr_val":"0","sample":"TCGA-OR-A5J2-01","attr_id":"LYMPH_NODES_EXAMINED_HE_COUNT"},{"attr_val":"YES","sample":"TCGA-OR-A5J2-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"0","sample":"TCGA-OR-A5J2-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Absent","sample":"TCGA-OR-A5J2-01","attr_id":"MITOTIC_RATE"},{"attr_val":"YES","sample":"TCGA-OR-A5J2-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5J2-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"DECEASED","sample":"TCGA-OR-A5J2-01","attr_id":"OS_STATUS"},{"attr_val":"8E7C2E31-D085-4B75-A970-162526DD07A0","sample":"TCGA-OR-A5J2-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"345C34EE-F031-41A4-B955-BA054F2A3CE1","sample":"TCGA-OR-A5J2-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5J2-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T3","sample":"TCGA-OR-A5J2-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5J2-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5J2-01","attr_id":"PHARM_TX_MITOTANE_FOR_MACRO_DISEASE"},{"attr_val":"YES","sample":"TCGA-OR-A5J2-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5J2-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_PROG"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5J2-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_MACRO"},{"attr_val":"NO","sample":"TCGA-OR-A5J2-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5J2-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5J2-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R2","sample":"TCGA-OR-A5J2-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5J2-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5J2-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5J2-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Progressive Disease","sample":"TCGA-OR-A5J2-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5J2-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5J2-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Dead","sample":"TCGA-OR-A5J2-01","attr_id":"VITAL_STATUS"},{"attr_val":"23","sample":"TCGA-OR-A5J3-01","attr_id":"AGE"},{"attr_val":"Stage III","sample":"TCGA-OR-A5J3-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Absent","sample":"TCGA-OR-A5J3-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5J3-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5J3-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5J3-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"1942","sample":"TCGA-OR-A5J3-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-8624","sample":"TCGA-OR-A5J3-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5J3-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5J3-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5J3-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Present","sample":"TCGA-OR-A5J3-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"HISPANIC OR LATINO","sample":"TCGA-OR-A5J3-01","attr_id":"ETHNICITY"},{"attr_val":"2013-12-2","sample":"TCGA-OR-A5J3-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5J3-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5J3-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Androgen|Cortisol","sample":"TCGA-OR-A5J3-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5J3-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5J3-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5J3-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5J3-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5J3-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5J3-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5J3-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2008","sample":"TCGA-OR-A5J3-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"310","sample":"TCGA-OR-A5J3-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5J3-01","attr_id":"LATERALITY"},{"attr_val":"4","sample":"TCGA-OR-A5J3-01","attr_id":"LYMPH_NODES_EXAMINED"},{"attr_val":"0","sample":"TCGA-OR-A5J3-01","attr_id":"LYMPH_NODES_EXAMINED_HE_COUNT"},{"attr_val":"YES","sample":"TCGA-OR-A5J3-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"6","sample":"TCGA-OR-A5J3-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Present","sample":"TCGA-OR-A5J3-01","attr_id":"MITOTIC_RATE"},{"attr_val":"YES","sample":"TCGA-OR-A5J3-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5J3-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5J3-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5J3-01","attr_id":"OS_STATUS"},{"attr_val":"DFD687BC-6E69-42F7-AF94-D17FC150D1A1","sample":"TCGA-OR-A5J3-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"83F53610-4F40-425B-9B69-BBB94234224F","sample":"TCGA-OR-A5J3-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5J3-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T3","sample":"TCGA-OR-A5J3-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5J3-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5J3-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5J3-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"YES","sample":"TCGA-OR-A5J3-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_REC"},{"attr_val":"YES","sample":"TCGA-OR-A5J3-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OR-A5J3-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5J3-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5J3-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5J3-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5J3-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5J3-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5J3-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Complete Remission\/Response","sample":"TCGA-OR-A5J3-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5J3-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5J3-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5J3-01","attr_id":"VITAL_STATUS"},{"attr_val":"23","sample":"TCGA-OR-A5J4-01","attr_id":"AGE"},{"attr_val":"Stage IV","sample":"TCGA-OR-A5J4-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Absent","sample":"TCGA-OR-A5J4-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M1","sample":"TCGA-OR-A5J4-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5J4-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Absent","sample":"TCGA-OR-A5J4-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"-8451","sample":"TCGA-OR-A5J4-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"423","sample":"TCGA-OR-A5J4-01","attr_id":"DAYS_TO_DEATH"},{"attr_val":"0","sample":"TCGA-OR-A5J4-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5J4-01","attr_id":"DFS_MONTHS"},{"attr_val":"NA","sample":"TCGA-OR-A5J4-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Present","sample":"TCGA-OR-A5J4-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"HISPANIC OR LATINO","sample":"TCGA-OR-A5J4-01","attr_id":"ETHNICITY"},{"attr_val":"2013-12-2","sample":"TCGA-OR-A5J4-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5J4-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5J4-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Androgen|Cortisol","sample":"TCGA-OR-A5J4-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5J4-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5J4-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5J4-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5J4-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5J4-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5J4-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5J4-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2000","sample":"TCGA-OR-A5J4-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"80","sample":"TCGA-OR-A5J4-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5J4-01","attr_id":"LATERALITY"},{"attr_val":"2","sample":"TCGA-OR-A5J4-01","attr_id":"LYMPH_NODES_EXAMINED"},{"attr_val":"2","sample":"TCGA-OR-A5J4-01","attr_id":"LYMPH_NODES_EXAMINED_HE_COUNT"},{"attr_val":"YES","sample":"TCGA-OR-A5J4-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"77","sample":"TCGA-OR-A5J4-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Present","sample":"TCGA-OR-A5J4-01","attr_id":"MITOTIC_RATE"},{"attr_val":"YES","sample":"TCGA-OR-A5J4-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5J4-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"DECEASED","sample":"TCGA-OR-A5J4-01","attr_id":"OS_STATUS"},{"attr_val":"5F3E2974-F1DF-47A2-8A8A-29BB525EEEF6","sample":"TCGA-OR-A5J4-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"39E300DC-C01F-46BC-AE4C-D834458F1FF7","sample":"TCGA-OR-A5J4-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N1","sample":"TCGA-OR-A5J4-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T3","sample":"TCGA-OR-A5J4-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5J4-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5J4-01","attr_id":"PHARM_TX_MITOTANE_FOR_MACRO_DISEASE"},{"attr_val":"YES","sample":"TCGA-OR-A5J4-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5J4-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_PROG"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5J4-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_MACRO"},{"attr_val":"NO","sample":"TCGA-OR-A5J4-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5J4-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5J4-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R2","sample":"TCGA-OR-A5J4-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5J4-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5J4-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5J4-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Progressive Disease","sample":"TCGA-OR-A5J4-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5J4-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5J4-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Dead","sample":"TCGA-OR-A5J4-01","attr_id":"VITAL_STATUS"},{"attr_val":"30","sample":"TCGA-OR-A5J5-01","attr_id":"AGE"},{"attr_val":"Stage III","sample":"TCGA-OR-A5J5-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Present","sample":"TCGA-OR-A5J5-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5J5-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5J5-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Absent","sample":"TCGA-OR-A5J5-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"-11171","sample":"TCGA-OR-A5J5-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"365","sample":"TCGA-OR-A5J5-01","attr_id":"DAYS_TO_DEATH"},{"attr_val":"0","sample":"TCGA-OR-A5J5-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5J5-01","attr_id":"DFS_MONTHS"},{"attr_val":"NA","sample":"TCGA-OR-A5J5-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Absent","sample":"TCGA-OR-A5J5-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"HISPANIC OR LATINO","sample":"TCGA-OR-A5J5-01","attr_id":"ETHNICITY"},{"attr_val":"2013-12-3","sample":"TCGA-OR-A5J5-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"MALE","sample":"TCGA-OR-A5J5-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5J5-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"None","sample":"TCGA-OR-A5J5-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"No","sample":"TCGA-OR-A5J5-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5J5-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5J5-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5J5-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5J5-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5J5-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2000","sample":"TCGA-OR-A5J5-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"40","sample":"TCGA-OR-A5J5-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5J5-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5J5-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"3","sample":"TCGA-OR-A5J5-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Absent","sample":"TCGA-OR-A5J5-01","attr_id":"MITOTIC_RATE"},{"attr_val":"YES","sample":"TCGA-OR-A5J5-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5J5-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"DECEASED","sample":"TCGA-OR-A5J5-01","attr_id":"OS_STATUS"},{"attr_val":"802DBD0D-EF07-4C91-AB8D-1DD39532E947","sample":"TCGA-OR-A5J5-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"BB63299C-B7F7-4F08-998D-C30E56CD6065","sample":"TCGA-OR-A5J5-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5J5-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T4","sample":"TCGA-OR-A5J5-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5J5-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5J5-01","attr_id":"PHARM_TX_MITOTANE_FOR_MACRO_DISEASE"},{"attr_val":"YES","sample":"TCGA-OR-A5J5-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5J5-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_PROG"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5J5-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_MACRO"},{"attr_val":"NO","sample":"TCGA-OR-A5J5-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5J5-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5J5-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R2","sample":"TCGA-OR-A5J5-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5J5-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5J5-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5J5-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Progressive Disease","sample":"TCGA-OR-A5J5-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5J5-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5J5-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Dead","sample":"TCGA-OR-A5J5-01","attr_id":"VITAL_STATUS"},{"attr_val":"29","sample":"TCGA-OR-A5J6-01","attr_id":"AGE"},{"attr_val":"Stage II","sample":"TCGA-OR-A5J6-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Absent","sample":"TCGA-OR-A5J6-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5J6-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5J6-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5J6-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"2428","sample":"TCGA-OR-A5J6-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-10839","sample":"TCGA-OR-A5J6-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5J6-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5J6-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5J6-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Present","sample":"TCGA-OR-A5J6-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"HISPANIC OR LATINO","sample":"TCGA-OR-A5J6-01","attr_id":"ETHNICITY"},{"attr_val":"2013-12-3","sample":"TCGA-OR-A5J6-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5J6-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5J6-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Androgen|Cortisol","sample":"TCGA-OR-A5J6-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5J6-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5J6-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5J6-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5J6-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5J6-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5J6-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5J6-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2006","sample":"TCGA-OR-A5J6-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"340","sample":"TCGA-OR-A5J6-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5J6-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5J6-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"Mitotic Rate > 5\/50 HPF Present","sample":"TCGA-OR-A5J6-01","attr_id":"MITOTIC_RATE"},{"attr_val":"NO","sample":"TCGA-OR-A5J6-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Absent","sample":"TCGA-OR-A5J6-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5J6-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5J6-01","attr_id":"OS_STATUS"},{"attr_val":"C8898B42-B704-45A0-9829-144B98F416E0","sample":"TCGA-OR-A5J6-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"F664D25E-9050-460D-AEAE-AA4BFA515453","sample":"TCGA-OR-A5J6-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5J6-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5J6-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5J6-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5J6-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5J6-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"BLACK OR AFRICAN AMERICAN","sample":"TCGA-OR-A5J6-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5J6-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5J6-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5J6-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5J6-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5J6-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Complete Remission\/Response","sample":"TCGA-OR-A5J6-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5J6-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5J6-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5J6-01","attr_id":"VITAL_STATUS"},{"attr_val":"30","sample":"TCGA-OR-A5J7-01","attr_id":"AGE"},{"attr_val":"Stage III","sample":"TCGA-OR-A5J7-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Present","sample":"TCGA-OR-A5J7-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5J7-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5J7-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5J7-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"-11279","sample":"TCGA-OR-A5J7-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"490","sample":"TCGA-OR-A5J7-01","attr_id":"DAYS_TO_DEATH"},{"attr_val":"0","sample":"TCGA-OR-A5J7-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5J7-01","attr_id":"DFS_MONTHS"},{"attr_val":"NA","sample":"TCGA-OR-A5J7-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Absent","sample":"TCGA-OR-A5J7-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"HISPANIC OR LATINO","sample":"TCGA-OR-A5J7-01","attr_id":"ETHNICITY"},{"attr_val":"2013-12-2","sample":"TCGA-OR-A5J7-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5J7-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5J7-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Androgen|Cortisol","sample":"TCGA-OR-A5J7-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5J7-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5J7-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5J7-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5J7-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5J7-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5J7-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5J7-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2009","sample":"TCGA-OR-A5J7-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"120","sample":"TCGA-OR-A5J7-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5J7-01","attr_id":"LATERALITY"},{"attr_val":"1","sample":"TCGA-OR-A5J7-01","attr_id":"LYMPH_NODES_EXAMINED"},{"attr_val":"0","sample":"TCGA-OR-A5J7-01","attr_id":"LYMPH_NODES_EXAMINED_HE_COUNT"},{"attr_val":"YES","sample":"TCGA-OR-A5J7-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"3","sample":"TCGA-OR-A5J7-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Absent","sample":"TCGA-OR-A5J7-01","attr_id":"MITOTIC_RATE"},{"attr_val":"YES","sample":"TCGA-OR-A5J7-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5J7-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"DECEASED","sample":"TCGA-OR-A5J7-01","attr_id":"OS_STATUS"},{"attr_val":"075DBFD0-9CF4-4877-884F-AE858902C79E","sample":"TCGA-OR-A5J7-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"F9C1971C-5BE2-4722-9A6C-CF4A4AD04352","sample":"TCGA-OR-A5J7-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5J7-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T3","sample":"TCGA-OR-A5J7-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5J7-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5J7-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5J7-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5J7-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OR-A5J7-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5J7-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5J7-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R1","sample":"TCGA-OR-A5J7-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5J7-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5J7-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5J7-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Progressive Disease","sample":"TCGA-OR-A5J7-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5J7-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5J7-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Dead","sample":"TCGA-OR-A5J7-01","attr_id":"VITAL_STATUS"},{"attr_val":"66","sample":"TCGA-OR-A5J8-01","attr_id":"AGE"},{"attr_val":"Stage III","sample":"TCGA-OR-A5J8-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Present","sample":"TCGA-OR-A5J8-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5J8-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5J8-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5J8-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"-24266","sample":"TCGA-OR-A5J8-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"579","sample":"TCGA-OR-A5J8-01","attr_id":"DAYS_TO_DEATH"},{"attr_val":"0","sample":"TCGA-OR-A5J8-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5J8-01","attr_id":"DFS_MONTHS"},{"attr_val":"NA","sample":"TCGA-OR-A5J8-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Present","sample":"TCGA-OR-A5J8-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"HISPANIC OR LATINO","sample":"TCGA-OR-A5J8-01","attr_id":"ETHNICITY"},{"attr_val":"2013-12-3","sample":"TCGA-OR-A5J8-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"MALE","sample":"TCGA-OR-A5J8-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5J8-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Cortisol","sample":"TCGA-OR-A5J8-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Biochemical Assessment","sample":"TCGA-OR-A5J8-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5J8-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5J8-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5J8-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5J8-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5J8-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5J8-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2011","sample":"TCGA-OR-A5J8-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"160","sample":"TCGA-OR-A5J8-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5J8-01","attr_id":"LATERALITY"},{"attr_val":"1","sample":"TCGA-OR-A5J8-01","attr_id":"LYMPH_NODES_EXAMINED"},{"attr_val":"0","sample":"TCGA-OR-A5J8-01","attr_id":"LYMPH_NODES_EXAMINED_HE_COUNT"},{"attr_val":"YES","sample":"TCGA-OR-A5J8-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"15","sample":"TCGA-OR-A5J8-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Present","sample":"TCGA-OR-A5J8-01","attr_id":"MITOTIC_RATE"},{"attr_val":"YES","sample":"TCGA-OR-A5J8-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5J8-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"DECEASED","sample":"TCGA-OR-A5J8-01","attr_id":"OS_STATUS"},{"attr_val":"08E0D412-D4D8-4D13-B792-A4DD0BD9EC2B","sample":"TCGA-OR-A5J8-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"EA68CD7A-9308-40CD-BB52-CEB36334A146","sample":"TCGA-OR-A5J8-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5J8-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T3","sample":"TCGA-OR-A5J8-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5J8-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5J8-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5J8-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5J8-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_REC"},{"attr_val":"NO","sample":"TCGA-OR-A5J8-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OR-A5J8-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5J8-01","attr_id":"RACE"},{"attr_val":"YES","sample":"TCGA-OR-A5J8-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5J8-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5J8-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5J8-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5J8-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Complete Remission\/Response","sample":"TCGA-OR-A5J8-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5J8-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5J8-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Dead","sample":"TCGA-OR-A5J8-01","attr_id":"VITAL_STATUS"},{"attr_val":"22","sample":"TCGA-OR-A5J9-01","attr_id":"AGE"},{"attr_val":"Stage II","sample":"TCGA-OR-A5J9-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Absent","sample":"TCGA-OR-A5J9-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5J9-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5J9-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5J9-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"1183","sample":"TCGA-OR-A5J9-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-8175","sample":"TCGA-OR-A5J9-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5J9-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5J9-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5J9-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Present","sample":"TCGA-OR-A5J9-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"HISPANIC OR LATINO","sample":"TCGA-OR-A5J9-01","attr_id":"ETHNICITY"},{"attr_val":"2013-12-3","sample":"TCGA-OR-A5J9-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5J9-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5J9-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"None","sample":"TCGA-OR-A5J9-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"No","sample":"TCGA-OR-A5J9-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5J9-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5J9-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5J9-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5J9-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5J9-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2010","sample":"TCGA-OR-A5J9-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"190","sample":"TCGA-OR-A5J9-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5J9-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5J9-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"6","sample":"TCGA-OR-A5J9-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Present","sample":"TCGA-OR-A5J9-01","attr_id":"MITOTIC_RATE"},{"attr_val":"YES","sample":"TCGA-OR-A5J9-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5J9-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5J9-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5J9-01","attr_id":"OS_STATUS"},{"attr_val":"A53E9117-0A49-40D8-AF40-7867370B671A","sample":"TCGA-OR-A5J9-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"4C775CF4-39D7-4246-87A4-4659783A1C18","sample":"TCGA-OR-A5J9-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5J9-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5J9-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5J9-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5J9-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5J9-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5J9-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_REC"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5J9-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OR-A5J9-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5J9-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5J9-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5J9-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5J9-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5J9-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5J9-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Complete Remission\/Response","sample":"TCGA-OR-A5J9-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5J9-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5J9-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5J9-01","attr_id":"VITAL_STATUS"},{"attr_val":"53","sample":"TCGA-OR-A5JA-01","attr_id":"AGE"},{"attr_val":"Stage IV","sample":"TCGA-OR-A5JA-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"M1","sample":"TCGA-OR-A5JA-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JA-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"-19436","sample":"TCGA-OR-A5JA-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"922","sample":"TCGA-OR-A5JA-01","attr_id":"DAYS_TO_DEATH"},{"attr_val":"0","sample":"TCGA-OR-A5JA-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5JA-01","attr_id":"DFS_MONTHS"},{"attr_val":"NA","sample":"TCGA-OR-A5JA-01","attr_id":"DFS_STATUS"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5JA-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-17","sample":"TCGA-OR-A5JA-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5JA-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5JA-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Androgen","sample":"TCGA-OR-A5JA-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5JA-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5JA-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5JA-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JA-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5JA-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JA-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5JA-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2004","sample":"TCGA-OR-A5JA-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"180","sample":"TCGA-OR-A5JA-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5JA-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5JA-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"90","sample":"TCGA-OR-A5JA-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"NO","sample":"TCGA-OR-A5JA-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"DECEASED","sample":"TCGA-OR-A5JA-01","attr_id":"OS_STATUS"},{"attr_val":"48402D61-3A6B-4603-BFA0-B1A38A47D34D","sample":"TCGA-OR-A5JA-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"6A505565-429B-4D8A-A591-AAB54CF43B66","sample":"TCGA-OR-A5JA-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5JA-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T4","sample":"TCGA-OR-A5JA-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JA-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5JA-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5JA-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5JA-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5JA-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R1","sample":"TCGA-OR-A5JA-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5JA-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5JA-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5JA-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5JA-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5JA-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Dead","sample":"TCGA-OR-A5JA-01","attr_id":"VITAL_STATUS"},{"attr_val":"52","sample":"TCGA-OR-A5JB-01","attr_id":"AGE"},{"attr_val":"Stage IV","sample":"TCGA-OR-A5JB-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Present","sample":"TCGA-OR-A5JB-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M1","sample":"TCGA-OR-A5JB-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JB-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5JB-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"-19172","sample":"TCGA-OR-A5JB-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"551","sample":"TCGA-OR-A5JB-01","attr_id":"DAYS_TO_DEATH"},{"attr_val":"0","sample":"TCGA-OR-A5JB-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5JB-01","attr_id":"DFS_MONTHS"},{"attr_val":"NA","sample":"TCGA-OR-A5JB-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Present","sample":"TCGA-OR-A5JB-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5JB-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-17","sample":"TCGA-OR-A5JB-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"MALE","sample":"TCGA-OR-A5JB-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5JB-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"None","sample":"TCGA-OR-A5JB-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"No","sample":"TCGA-OR-A5JB-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5JB-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JB-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5JB-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JB-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5JB-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2000","sample":"TCGA-OR-A5JB-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"20","sample":"TCGA-OR-A5JB-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5JB-01","attr_id":"LATERALITY"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JB-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"15","sample":"TCGA-OR-A5JB-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Present","sample":"TCGA-OR-A5JB-01","attr_id":"MITOTIC_RATE"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JB-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5JB-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"DECEASED","sample":"TCGA-OR-A5JB-01","attr_id":"OS_STATUS"},{"attr_val":"D63F2F1E-1970-445F-907B-23CF4D9EFD83","sample":"TCGA-OR-A5JB-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"81022A25-6D64-419D-9B97-22348E17ECEA","sample":"TCGA-OR-A5JB-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5JB-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T4","sample":"TCGA-OR-A5JB-01","attr_id":"PATH_T_STAGE"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JB-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JB-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5JB-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5JB-01","attr_id":"RACE"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JB-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R1","sample":"TCGA-OR-A5JB-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5JB-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5JB-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5JB-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JB-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JB-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5JB-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Dead","sample":"TCGA-OR-A5JB-01","attr_id":"VITAL_STATUS"},{"attr_val":"37","sample":"TCGA-OR-A5JC-01","attr_id":"AGE"},{"attr_val":"Atypical Mitotic Figures Present","sample":"TCGA-OR-A5JC-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JC-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5JC-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"-13862","sample":"TCGA-OR-A5JC-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"1750","sample":"TCGA-OR-A5JC-01","attr_id":"DAYS_TO_DEATH"},{"attr_val":"0","sample":"TCGA-OR-A5JC-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5JC-01","attr_id":"DFS_MONTHS"},{"attr_val":"NA","sample":"TCGA-OR-A5JC-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Present","sample":"TCGA-OR-A5JC-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5JC-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-17","sample":"TCGA-OR-A5JC-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"MALE","sample":"TCGA-OR-A5JC-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5JC-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Estrogen","sample":"TCGA-OR-A5JC-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Biochemical Assessment","sample":"TCGA-OR-A5JC-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5JC-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5JC-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JC-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5JC-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JC-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5JC-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2001","sample":"TCGA-OR-A5JC-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"30","sample":"TCGA-OR-A5JC-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5JC-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5JC-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"24","sample":"TCGA-OR-A5JC-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Present","sample":"TCGA-OR-A5JC-01","attr_id":"MITOTIC_RATE"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JC-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5JC-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"DECEASED","sample":"TCGA-OR-A5JC-01","attr_id":"OS_STATUS"},{"attr_val":"BDFCD747-F6A2-42E2-BC9B-483112205FA8","sample":"TCGA-OR-A5JC-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"328B8F7A-8CEC-4670-A83F-B16AF53E74CE","sample":"TCGA-OR-A5JC-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JC-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JC-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5JC-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5JC-01","attr_id":"RACE"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JC-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5JC-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5JC-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5JC-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JC-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5JC-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Dead","sample":"TCGA-OR-A5JC-01","attr_id":"VITAL_STATUS"},{"attr_val":"69","sample":"TCGA-OR-A5JF-01","attr_id":"AGE"},{"attr_val":"Stage II","sample":"TCGA-OR-A5JF-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Present","sample":"TCGA-OR-A5JF-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5JF-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5JF-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"1259","sample":"TCGA-OR-A5JF-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-25502","sample":"TCGA-OR-A5JF-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5JF-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5JF-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5JF-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Absent","sample":"TCGA-OR-A5JF-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5JF-01","attr_id":"ETHNICITY"},{"attr_val":"2013-10-3","sample":"TCGA-OR-A5JF-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5JF-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5JF-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Cortisol","sample":"TCGA-OR-A5JF-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Biochemical Assessment","sample":"TCGA-OR-A5JF-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5JF-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5JF-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JF-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5JF-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JF-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5JF-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2007","sample":"TCGA-OR-A5JF-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"30","sample":"TCGA-OR-A5JF-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5JF-01","attr_id":"LATERALITY"},{"attr_val":"4","sample":"TCGA-OR-A5JF-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Absent","sample":"TCGA-OR-A5JF-01","attr_id":"MITOTIC_RATE"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JF-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5JF-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5JF-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5JF-01","attr_id":"OS_STATUS"},{"attr_val":"DAFB9844-1A5C-4AF8-B382-59C751942BB8","sample":"TCGA-OR-A5JF-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"D9851FF2-70AC-45AD-AF18-B8A4B9F01E17","sample":"TCGA-OR-A5JF-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5JF-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5JF-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5JF-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5JF-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5JF-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5JF-01","attr_id":"RACE"},{"attr_val":"YES","sample":"TCGA-OR-A5JF-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5JF-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5JF-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5JF-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5JF-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Complete Remission\/Response","sample":"TCGA-OR-A5JF-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5JF-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5JF-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5JF-01","attr_id":"VITAL_STATUS"},{"attr_val":"61","sample":"TCGA-OR-A5JG-01","attr_id":"AGE"},{"attr_val":"Stage IV","sample":"TCGA-OR-A5JG-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"M1","sample":"TCGA-OR-A5JG-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JG-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"-22390","sample":"TCGA-OR-A5JG-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"541","sample":"TCGA-OR-A5JG-01","attr_id":"DAYS_TO_DEATH"},{"attr_val":"0","sample":"TCGA-OR-A5JG-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5JG-01","attr_id":"DFS_MONTHS"},{"attr_val":"NA","sample":"TCGA-OR-A5JG-01","attr_id":"DFS_STATUS"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5JG-01","attr_id":"ETHNICITY"},{"attr_val":"2013-10-3","sample":"TCGA-OR-A5JG-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"MALE","sample":"TCGA-OR-A5JG-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5JG-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Cortisol","sample":"TCGA-OR-A5JG-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5JG-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5JG-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5JG-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JG-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5JG-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JG-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5JG-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2008","sample":"TCGA-OR-A5JG-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"60","sample":"TCGA-OR-A5JG-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5JG-01","attr_id":"LATERALITY"},{"attr_val":"8","sample":"TCGA-OR-A5JG-01","attr_id":"LYMPH_NODES_EXAMINED"},{"attr_val":"6","sample":"TCGA-OR-A5JG-01","attr_id":"LYMPH_NODES_EXAMINED_HE_COUNT"},{"attr_val":"YES","sample":"TCGA-OR-A5JG-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"100","sample":"TCGA-OR-A5JG-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JG-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"DECEASED","sample":"TCGA-OR-A5JG-01","attr_id":"OS_STATUS"},{"attr_val":"71892706-F8B6-44E6-8DE4-6CBB43F612E0","sample":"TCGA-OR-A5JG-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"15F6D8D6-878A-410F-8289-D3CEAB7E5D21","sample":"TCGA-OR-A5JG-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N1","sample":"TCGA-OR-A5JG-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T4","sample":"TCGA-OR-A5JG-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JG-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JG-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5JG-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JG-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OR-A5JG-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5JG-01","attr_id":"RACE"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JG-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R1","sample":"TCGA-OR-A5JG-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5JG-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5JG-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5JG-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5JG-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5JG-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Dead","sample":"TCGA-OR-A5JG-01","attr_id":"VITAL_STATUS"},{"attr_val":"22","sample":"TCGA-OR-A5JI-01","attr_id":"AGE"},{"attr_val":"Stage I","sample":"TCGA-OR-A5JI-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Absent","sample":"TCGA-OR-A5JI-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5JI-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JI-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5JI-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"1424","sample":"TCGA-OR-A5JI-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-8177","sample":"TCGA-OR-A5JI-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5JI-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5JI-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5JI-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Present","sample":"TCGA-OR-A5JI-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5JI-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-18","sample":"TCGA-OR-A5JI-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"MALE","sample":"TCGA-OR-A5JI-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5JI-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"None","sample":"TCGA-OR-A5JI-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"No","sample":"TCGA-OR-A5JI-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5JI-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JI-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5JI-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JI-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5JI-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2008","sample":"TCGA-OR-A5JI-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"20","sample":"TCGA-OR-A5JI-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5JI-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5JI-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"1","sample":"TCGA-OR-A5JI-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Absent","sample":"TCGA-OR-A5JI-01","attr_id":"MITOTIC_RATE"},{"attr_val":"NO","sample":"TCGA-OR-A5JI-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5JI-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5JI-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5JI-01","attr_id":"OS_STATUS"},{"attr_val":"B7ADB786-1F81-43CA-AC72-7243966CD439","sample":"TCGA-OR-A5JI-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"F18AFE4B-5333-418A-A6D0-E347ACA3C06B","sample":"TCGA-OR-A5JI-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5JI-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T1","sample":"TCGA-OR-A5JI-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5JI-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5JI-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5JI-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5JI-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5JI-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5JI-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5JI-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5JI-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5JI-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5JI-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5JI-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5JI-01","attr_id":"VITAL_STATUS"},{"attr_val":"65","sample":"TCGA-OR-A5JJ-01","attr_id":"AGE"},{"attr_val":"Stage IV","sample":"TCGA-OR-A5JJ-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Present","sample":"TCGA-OR-A5JJ-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M1","sample":"TCGA-OR-A5JJ-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JJ-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5JJ-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"309","sample":"TCGA-OR-A5JJ-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-24082","sample":"TCGA-OR-A5JJ-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5JJ-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5JJ-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5JJ-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Present","sample":"TCGA-OR-A5JJ-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5JJ-01","attr_id":"ETHNICITY"},{"attr_val":"2013-10-3","sample":"TCGA-OR-A5JJ-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"MALE","sample":"TCGA-OR-A5JJ-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5JJ-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"None","sample":"TCGA-OR-A5JJ-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"No","sample":"TCGA-OR-A5JJ-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5JJ-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JJ-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5JJ-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JJ-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5JJ-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2009","sample":"TCGA-OR-A5JJ-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"40","sample":"TCGA-OR-A5JJ-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5JJ-01","attr_id":"LATERALITY"},{"attr_val":"6","sample":"TCGA-OR-A5JJ-01","attr_id":"LYMPH_NODES_EXAMINED"},{"attr_val":"6","sample":"TCGA-OR-A5JJ-01","attr_id":"LYMPH_NODES_EXAMINED_HE_COUNT"},{"attr_val":"YES","sample":"TCGA-OR-A5JJ-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"50","sample":"TCGA-OR-A5JJ-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Present","sample":"TCGA-OR-A5JJ-01","attr_id":"MITOTIC_RATE"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JJ-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5JJ-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5JJ-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5JJ-01","attr_id":"OS_STATUS"},{"attr_val":"9EC86C06-E7A9-4EA6-B36D-6F832909054B","sample":"TCGA-OR-A5JJ-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"AF7A85AB-4C73-40B8-B913-9E540FEDE0FC","sample":"TCGA-OR-A5JJ-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N1","sample":"TCGA-OR-A5JJ-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T4","sample":"TCGA-OR-A5JJ-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5JJ-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JJ-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5JJ-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5JJ-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5JJ-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5JJ-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R2","sample":"TCGA-OR-A5JJ-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5JJ-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5JJ-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5JJ-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5JJ-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5JJ-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5JJ-01","attr_id":"VITAL_STATUS"},{"attr_val":"49","sample":"TCGA-OR-A5JK-01","attr_id":"AGE"},{"attr_val":"Stage IV","sample":"TCGA-OR-A5JK-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Present","sample":"TCGA-OR-A5JK-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M1","sample":"TCGA-OR-A5JK-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JK-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5JK-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"1255","sample":"TCGA-OR-A5JK-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-18214","sample":"TCGA-OR-A5JK-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5JK-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5JK-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5JK-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Present","sample":"TCGA-OR-A5JK-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5JK-01","attr_id":"ETHNICITY"},{"attr_val":"2013-10-3","sample":"TCGA-OR-A5JK-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"MALE","sample":"TCGA-OR-A5JK-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5JK-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"None","sample":"TCGA-OR-A5JK-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"No","sample":"TCGA-OR-A5JK-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5JK-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JK-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5JK-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JK-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5JK-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2009","sample":"TCGA-OR-A5JK-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"60","sample":"TCGA-OR-A5JK-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5JK-01","attr_id":"LATERALITY"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JK-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"4","sample":"TCGA-OR-A5JK-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Absent","sample":"TCGA-OR-A5JK-01","attr_id":"MITOTIC_RATE"},{"attr_val":"NO","sample":"TCGA-OR-A5JK-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5JK-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5JK-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5JK-01","attr_id":"OS_STATUS"},{"attr_val":"A477B55D-A591-482F-A554-D8EF7298C23D","sample":"TCGA-OR-A5JK-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"69DBF44F-F313-423E-8DD7-E3F80AE875B8","sample":"TCGA-OR-A5JK-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5JK-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T4","sample":"TCGA-OR-A5JK-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5JK-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JK-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5JK-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5JK-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5JK-01","attr_id":"RACE"},{"attr_val":"YES","sample":"TCGA-OR-A5JK-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R2","sample":"TCGA-OR-A5JK-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5JK-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5JK-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5JK-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5JK-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5JK-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5JK-01","attr_id":"VITAL_STATUS"},{"attr_val":"36","sample":"TCGA-OR-A5JL-01","attr_id":"AGE"},{"attr_val":"Stage I","sample":"TCGA-OR-A5JL-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"M0","sample":"TCGA-OR-A5JL-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JL-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"670","sample":"TCGA-OR-A5JL-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-13155","sample":"TCGA-OR-A5JL-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5JL-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5JL-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5JL-01","attr_id":"DFS_STATUS"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5JL-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-18","sample":"TCGA-OR-A5JL-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5JL-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5JL-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Androgen","sample":"TCGA-OR-A5JL-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5JL-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5JL-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5JL-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JL-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5JL-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JL-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5JL-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2009","sample":"TCGA-OR-A5JL-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"60","sample":"TCGA-OR-A5JL-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5JL-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5JL-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"6","sample":"TCGA-OR-A5JL-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"NO","sample":"TCGA-OR-A5JL-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"NA","sample":"TCGA-OR-A5JL-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5JL-01","attr_id":"OS_STATUS"},{"attr_val":"0ACC28BC-D348-41DF-8F49-BC0332EB9BE4","sample":"TCGA-OR-A5JL-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"BD8435C3-C525-472C-8B43-EC2CAE22B785","sample":"TCGA-OR-A5JL-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5JL-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T1","sample":"TCGA-OR-A5JL-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5JL-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5JL-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5JL-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JL-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_REC"},{"attr_val":"YES","sample":"TCGA-OR-A5JL-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JL-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_MACRO"},{"attr_val":"NO","sample":"TCGA-OR-A5JL-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5JL-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5JL-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5JL-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5JL-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5JL-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5JL-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Complete Remission\/Response","sample":"TCGA-OR-A5JL-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5JL-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5JL-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5JL-01","attr_id":"VITAL_STATUS"},{"attr_val":"25","sample":"TCGA-OR-A5JM-01","attr_id":"AGE"},{"attr_val":"Stage IV","sample":"TCGA-OR-A5JM-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Present","sample":"TCGA-OR-A5JM-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M1","sample":"TCGA-OR-A5JM-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JM-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5JM-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"-9359","sample":"TCGA-OR-A5JM-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"562","sample":"TCGA-OR-A5JM-01","attr_id":"DAYS_TO_DEATH"},{"attr_val":"0","sample":"TCGA-OR-A5JM-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5JM-01","attr_id":"DFS_MONTHS"},{"attr_val":"NA","sample":"TCGA-OR-A5JM-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Present","sample":"TCGA-OR-A5JM-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5JM-01","attr_id":"ETHNICITY"},{"attr_val":"2013-10-3","sample":"TCGA-OR-A5JM-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5JM-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5JM-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Cortisol","sample":"TCGA-OR-A5JM-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5JM-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"Yes","sample":"TCGA-OR-A5JM-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5JM-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JM-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5JM-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JM-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5JM-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2011","sample":"TCGA-OR-A5JM-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"70","sample":"TCGA-OR-A5JM-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5JM-01","attr_id":"LATERALITY"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JM-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"90","sample":"TCGA-OR-A5JM-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Present","sample":"TCGA-OR-A5JM-01","attr_id":"MITOTIC_RATE"},{"attr_val":"YES","sample":"TCGA-OR-A5JM-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5JM-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"DECEASED","sample":"TCGA-OR-A5JM-01","attr_id":"OS_STATUS"},{"attr_val":"FB54458D-C373-46C2-841E-82663E13EFAA","sample":"TCGA-OR-A5JM-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"A214150E-54BD-499D-A56D-082BAC861668","sample":"TCGA-OR-A5JM-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5JM-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T4","sample":"TCGA-OR-A5JM-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JM-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5JM-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5JM-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JM-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OR-A5JM-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5JM-01","attr_id":"RACE"},{"attr_val":"YES","sample":"TCGA-OR-A5JM-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R1","sample":"TCGA-OR-A5JM-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5JM-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5JM-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5JM-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Progressive Disease","sample":"TCGA-OR-A5JM-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5JM-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5JM-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Dead","sample":"TCGA-OR-A5JM-01","attr_id":"VITAL_STATUS"},{"attr_val":"26","sample":"TCGA-OR-A5JO-01","attr_id":"AGE"},{"attr_val":"Stage I","sample":"TCGA-OR-A5JO-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Absent","sample":"TCGA-OR-A5JO-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5JO-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JO-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Absent","sample":"TCGA-OR-A5JO-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"889","sample":"TCGA-OR-A5JO-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-9547","sample":"TCGA-OR-A5JO-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5JO-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5JO-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5JO-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Present","sample":"TCGA-OR-A5JO-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5JO-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-18","sample":"TCGA-OR-A5JO-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5JO-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5JO-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"None","sample":"TCGA-OR-A5JO-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"No","sample":"TCGA-OR-A5JO-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5JO-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JO-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5JO-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JO-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5JO-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2005","sample":"TCGA-OR-A5JO-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"20","sample":"TCGA-OR-A5JO-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5JO-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5JO-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"2","sample":"TCGA-OR-A5JO-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Absent","sample":"TCGA-OR-A5JO-01","attr_id":"MITOTIC_RATE"},{"attr_val":"NO","sample":"TCGA-OR-A5JO-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5JO-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5JO-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5JO-01","attr_id":"OS_STATUS"},{"attr_val":"4FBBBE43-3C0E-4475-BCF8-3745BD7195EB","sample":"TCGA-OR-A5JO-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"1FECADEA-0B65-451D-933D-2217F9119D35","sample":"TCGA-OR-A5JO-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5JO-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T1","sample":"TCGA-OR-A5JO-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5JO-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5JO-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5JO-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5JO-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5JO-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5JO-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5JO-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5JO-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5JO-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5JO-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5JO-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5JO-01","attr_id":"VITAL_STATUS"},{"attr_val":"26","sample":"TCGA-OR-A5JQ-01","attr_id":"AGE"},{"attr_val":"Stage II","sample":"TCGA-OR-A5JQ-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Absent","sample":"TCGA-OR-A5JQ-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5JQ-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JQ-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5JQ-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"674","sample":"TCGA-OR-A5JQ-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-9667","sample":"TCGA-OR-A5JQ-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5JQ-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5JQ-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5JQ-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Present","sample":"TCGA-OR-A5JQ-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5JQ-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-18","sample":"TCGA-OR-A5JQ-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5JQ-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical Carcinoma- Myxoid Type","sample":"TCGA-OR-A5JQ-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"None","sample":"TCGA-OR-A5JQ-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"No","sample":"TCGA-OR-A5JQ-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5JQ-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JQ-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5JQ-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JQ-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5JQ-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2006","sample":"TCGA-OR-A5JQ-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"40","sample":"TCGA-OR-A5JQ-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5JQ-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5JQ-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"3","sample":"TCGA-OR-A5JQ-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Absent","sample":"TCGA-OR-A5JQ-01","attr_id":"MITOTIC_RATE"},{"attr_val":"NO","sample":"TCGA-OR-A5JQ-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5JQ-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5JQ-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5JQ-01","attr_id":"OS_STATUS"},{"attr_val":"199560CB-15E5-4276-865A-7D44D47C856C","sample":"TCGA-OR-A5JQ-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"3AE0E638-5907-4B56-9C55-E58D97B27AFF","sample":"TCGA-OR-A5JQ-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5JQ-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5JQ-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5JQ-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5JQ-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5JQ-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5JQ-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5JQ-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5JQ-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5JQ-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5JQ-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5JQ-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Complete Remission\/Response","sample":"TCGA-OR-A5JQ-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5JQ-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5JQ-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5JQ-01","attr_id":"VITAL_STATUS"},{"attr_val":"45","sample":"TCGA-OR-A5JR-01","attr_id":"AGE"},{"attr_val":"Stage I","sample":"TCGA-OR-A5JR-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"M0","sample":"TCGA-OR-A5JR-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JR-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"3688","sample":"TCGA-OR-A5JR-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-16604","sample":"TCGA-OR-A5JR-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5JR-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5JR-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5JR-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Absent","sample":"TCGA-OR-A5JR-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5JR-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-9","sample":"TCGA-OR-A5JR-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"MALE","sample":"TCGA-OR-A5JR-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5JR-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"None","sample":"TCGA-OR-A5JR-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"No","sample":"TCGA-OR-A5JR-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5JR-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JR-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5JR-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JR-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5JR-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2002","sample":"TCGA-OR-A5JR-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"80","sample":"TCGA-OR-A5JR-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5JR-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5JR-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"NO","sample":"TCGA-OR-A5JR-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Absent","sample":"TCGA-OR-A5JR-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5JR-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5JR-01","attr_id":"OS_STATUS"},{"attr_val":"A19104D6-B6A6-4878-AF2C-783679070A05","sample":"TCGA-OR-A5JR-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"33E0DEF4-2538-4C8B-A71C-11B4F9D57E32","sample":"TCGA-OR-A5JR-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5JR-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T1","sample":"TCGA-OR-A5JR-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5JR-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5JR-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5JR-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5JR-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5JR-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5JR-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5JR-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5JR-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5JR-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Complete Remission\/Response","sample":"TCGA-OR-A5JR-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5JR-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5JR-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5JR-01","attr_id":"VITAL_STATUS"},{"attr_val":"65","sample":"TCGA-OR-A5JS-01","attr_id":"AGE"},{"attr_val":"Stage II","sample":"TCGA-OR-A5JS-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"M0","sample":"TCGA-OR-A5JS-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JS-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"383","sample":"TCGA-OR-A5JS-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-24017","sample":"TCGA-OR-A5JS-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5JS-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5JS-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5JS-01","attr_id":"DFS_STATUS"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5JS-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-9","sample":"TCGA-OR-A5JS-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5JS-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5JS-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"None","sample":"TCGA-OR-A5JS-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"No","sample":"TCGA-OR-A5JS-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5JS-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JS-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5JS-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JS-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5JS-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2011","sample":"TCGA-OR-A5JS-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"150","sample":"TCGA-OR-A5JS-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5JS-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5JS-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"35","sample":"TCGA-OR-A5JS-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Present","sample":"TCGA-OR-A5JS-01","attr_id":"MITOTIC_RATE"},{"attr_val":"YES","sample":"TCGA-OR-A5JS-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"NA","sample":"TCGA-OR-A5JS-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5JS-01","attr_id":"OS_STATUS"},{"attr_val":"82940E94-AC74-4A9B-9DA5-9E4B7D4D45C0","sample":"TCGA-OR-A5JS-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"B6E65697-5AE8-45B4-9FAA-D25B8F57988F","sample":"TCGA-OR-A5JS-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5JS-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5JS-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5JS-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5JS-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5JS-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5JS-01","attr_id":"RACE"},{"attr_val":"YES","sample":"TCGA-OR-A5JS-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5JS-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5JS-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5JS-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5JS-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JS-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5JS-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5JS-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5JS-01","attr_id":"VITAL_STATUS"},{"attr_val":"65","sample":"TCGA-OR-A5JT-01","attr_id":"AGE"},{"attr_val":"Stage II","sample":"TCGA-OR-A5JT-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"M0","sample":"TCGA-OR-A5JT-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JT-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"488","sample":"TCGA-OR-A5JT-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-23794","sample":"TCGA-OR-A5JT-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5JT-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5JT-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5JT-01","attr_id":"DFS_STATUS"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5JT-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-9","sample":"TCGA-OR-A5JT-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5JT-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5JT-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Biochemical Assessment","sample":"TCGA-OR-A5JT-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5JT-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5JT-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JT-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5JT-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JT-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5JT-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2011","sample":"TCGA-OR-A5JT-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"140","sample":"TCGA-OR-A5JT-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5JT-01","attr_id":"LATERALITY"},{"attr_val":"17","sample":"TCGA-OR-A5JT-01","attr_id":"LYMPH_NODES_EXAMINED"},{"attr_val":"0","sample":"TCGA-OR-A5JT-01","attr_id":"LYMPH_NODES_EXAMINED_HE_COUNT"},{"attr_val":"YES","sample":"TCGA-OR-A5JT-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"5","sample":"TCGA-OR-A5JT-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Absent","sample":"TCGA-OR-A5JT-01","attr_id":"MITOTIC_RATE"},{"attr_val":"NO","sample":"TCGA-OR-A5JT-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"NA","sample":"TCGA-OR-A5JT-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5JT-01","attr_id":"OS_STATUS"},{"attr_val":"C0E1A036-BE4C-4FB5-BB50-E2431BE60ED4","sample":"TCGA-OR-A5JT-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"095AE671-9808-4895-B6FD-EDA3F7F9E69D","sample":"TCGA-OR-A5JT-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5JT-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5JT-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5JT-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5JT-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5JT-01","attr_id":"PHARM_TX_MITOTANE_FOR_MACRO_DISEASE"},{"attr_val":"YES","sample":"TCGA-OR-A5JT-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5JT-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_PROG"},{"attr_val":"YES","sample":"TCGA-OR-A5JT-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_REC"},{"attr_val":"YES","sample":"TCGA-OR-A5JT-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OR-A5JT-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5JT-01","attr_id":"RACE"},{"attr_val":"YES","sample":"TCGA-OR-A5JT-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5JT-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5JT-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5JT-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5JT-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JT-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"A","sample":"TCGA-OR-A5JT-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5JT-01","attr_id":"VITAL_STATUS"},{"attr_val":"55","sample":"TCGA-OR-A5JV-01","attr_id":"AGE"},{"attr_val":"Stage II","sample":"TCGA-OR-A5JV-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"M0","sample":"TCGA-OR-A5JV-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JV-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"1541","sample":"TCGA-OR-A5JV-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-20319","sample":"TCGA-OR-A5JV-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5JV-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5JV-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5JV-01","attr_id":"DFS_STATUS"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5JV-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-9","sample":"TCGA-OR-A5JV-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"MALE","sample":"TCGA-OR-A5JV-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5JV-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"None","sample":"TCGA-OR-A5JV-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"No","sample":"TCGA-OR-A5JV-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5JV-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JV-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5JV-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JV-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5JV-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2008","sample":"TCGA-OR-A5JV-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"110","sample":"TCGA-OR-A5JV-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5JV-01","attr_id":"LATERALITY"},{"attr_val":"1","sample":"TCGA-OR-A5JV-01","attr_id":"LYMPH_NODES_EXAMINED"},{"attr_val":"0","sample":"TCGA-OR-A5JV-01","attr_id":"LYMPH_NODES_EXAMINED_HE_COUNT"},{"attr_val":"YES","sample":"TCGA-OR-A5JV-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"NO","sample":"TCGA-OR-A5JV-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"NA","sample":"TCGA-OR-A5JV-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5JV-01","attr_id":"OS_STATUS"},{"attr_val":"388B8788-A635-4BC9-9B73-D204B2256747","sample":"TCGA-OR-A5JV-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"35A41AE5-44E3-45D1-A2C0-523496732A75","sample":"TCGA-OR-A5JV-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5JV-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5JV-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5JV-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5JV-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5JV-01","attr_id":"PHARM_TX_MITOTANE_FOR_MACRO_DISEASE"},{"attr_val":"YES","sample":"TCGA-OR-A5JV-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5JV-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_REC"},{"attr_val":"YES","sample":"TCGA-OR-A5JV-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OR-A5JV-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5JV-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5JV-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5JV-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5JV-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5JV-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5JV-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5JV-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5JV-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5JV-01","attr_id":"VITAL_STATUS"},{"attr_val":"47","sample":"TCGA-OR-A5JW-01","attr_id":"AGE"},{"attr_val":"Stage II","sample":"TCGA-OR-A5JW-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"M0","sample":"TCGA-OR-A5JW-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JW-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"1924","sample":"TCGA-OR-A5JW-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-17513","sample":"TCGA-OR-A5JW-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5JW-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5JW-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5JW-01","attr_id":"DFS_STATUS"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5JW-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-9","sample":"TCGA-OR-A5JW-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"MALE","sample":"TCGA-OR-A5JW-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5JW-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Cortisol","sample":"TCGA-OR-A5JW-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5JW-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5JW-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5JW-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JW-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5JW-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JW-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5JW-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2008","sample":"TCGA-OR-A5JW-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"140","sample":"TCGA-OR-A5JW-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5JW-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5JW-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"NO","sample":"TCGA-OR-A5JW-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"NA","sample":"TCGA-OR-A5JW-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5JW-01","attr_id":"OS_STATUS"},{"attr_val":"63B7B596-CB55-41DC-B862-A6C3A058DFE2","sample":"TCGA-OR-A5JW-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"54BAF12C-F096-4415-BFF0-DD35D22E932B","sample":"TCGA-OR-A5JW-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5JW-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5JW-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5JW-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5JW-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5JW-01","attr_id":"PHARM_TX_MITOTANE_FOR_MACRO_DISEASE"},{"attr_val":"YES","sample":"TCGA-OR-A5JW-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"YES","sample":"TCGA-OR-A5JW-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OR-A5JW-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5JW-01","attr_id":"RACE"},{"attr_val":"YES","sample":"TCGA-OR-A5JW-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5JW-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5JW-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5JW-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5JW-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5JW-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5JW-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5JW-01","attr_id":"VITAL_STATUS"},{"attr_val":"50","sample":"TCGA-OR-A5JX-01","attr_id":"AGE"},{"attr_val":"Stage III","sample":"TCGA-OR-A5JX-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"M0","sample":"TCGA-OR-A5JX-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JX-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"950","sample":"TCGA-OR-A5JX-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-18402","sample":"TCGA-OR-A5JX-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5JX-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5JX-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5JX-01","attr_id":"DFS_STATUS"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5JX-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-10","sample":"TCGA-OR-A5JX-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"MALE","sample":"TCGA-OR-A5JX-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5JX-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"None","sample":"TCGA-OR-A5JX-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"No","sample":"TCGA-OR-A5JX-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5JX-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JX-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5JX-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JX-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5JX-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2009","sample":"TCGA-OR-A5JX-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"120","sample":"TCGA-OR-A5JX-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5JX-01","attr_id":"LATERALITY"},{"attr_val":"1","sample":"TCGA-OR-A5JX-01","attr_id":"LYMPH_NODES_EXAMINED"},{"attr_val":"0","sample":"TCGA-OR-A5JX-01","attr_id":"LYMPH_NODES_EXAMINED_HE_COUNT"},{"attr_val":"YES","sample":"TCGA-OR-A5JX-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"5","sample":"TCGA-OR-A5JX-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Absent","sample":"TCGA-OR-A5JX-01","attr_id":"MITOTIC_RATE"},{"attr_val":"NO","sample":"TCGA-OR-A5JX-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"NA","sample":"TCGA-OR-A5JX-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5JX-01","attr_id":"OS_STATUS"},{"attr_val":"42F69B2B-F3AA-4F4E-AC3A-149E14789927","sample":"TCGA-OR-A5JX-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"6F548B5E-C4A2-46C7-8B56-7DD037CC49B5","sample":"TCGA-OR-A5JX-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5JX-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T3","sample":"TCGA-OR-A5JX-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5JX-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5JX-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5JX-01","attr_id":"PHARM_TX_MITOTANE_FOR_MACRO_DISEASE"},{"attr_val":"YES","sample":"TCGA-OR-A5JX-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5JX-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_REC"},{"attr_val":"YES","sample":"TCGA-OR-A5JX-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OR-A5JX-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5JX-01","attr_id":"RACE"},{"attr_val":"YES","sample":"TCGA-OR-A5JX-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5JX-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5JX-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5JX-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5JX-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5JX-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5JX-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5JX-01","attr_id":"VITAL_STATUS"},{"attr_val":"68","sample":"TCGA-OR-A5JY-01","attr_id":"AGE"},{"attr_val":"Stage IV","sample":"TCGA-OR-A5JY-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"M1","sample":"TCGA-OR-A5JY-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JY-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"-25190","sample":"TCGA-OR-A5JY-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"552","sample":"TCGA-OR-A5JY-01","attr_id":"DAYS_TO_DEATH"},{"attr_val":"0","sample":"TCGA-OR-A5JY-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5JY-01","attr_id":"DFS_MONTHS"},{"attr_val":"NA","sample":"TCGA-OR-A5JY-01","attr_id":"DFS_STATUS"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5JY-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-10","sample":"TCGA-OR-A5JY-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5JY-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5JY-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Androgen|Cortisol","sample":"TCGA-OR-A5JY-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5JY-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5JY-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5JY-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JY-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5JY-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JY-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5JY-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2011","sample":"TCGA-OR-A5JY-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"190","sample":"TCGA-OR-A5JY-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5JY-01","attr_id":"LATERALITY"},{"attr_val":"2","sample":"TCGA-OR-A5JY-01","attr_id":"LYMPH_NODES_EXAMINED"},{"attr_val":"1","sample":"TCGA-OR-A5JY-01","attr_id":"LYMPH_NODES_EXAMINED_HE_COUNT"},{"attr_val":"YES","sample":"TCGA-OR-A5JY-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"60","sample":"TCGA-OR-A5JY-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Present","sample":"TCGA-OR-A5JY-01","attr_id":"MITOTIC_RATE"},{"attr_val":"YES","sample":"TCGA-OR-A5JY-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"DECEASED","sample":"TCGA-OR-A5JY-01","attr_id":"OS_STATUS"},{"attr_val":"344F7EA4-2BD4-4F2D-89F2-9FC7F572A3D6","sample":"TCGA-OR-A5JY-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"8D4E0E4D-9C84-4F29-AFD9-91EEEC158ED6","sample":"TCGA-OR-A5JY-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N1","sample":"TCGA-OR-A5JY-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T4","sample":"TCGA-OR-A5JY-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JY-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5JY-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5JY-01","attr_id":"PHARM_TX_MITOTANE_FOR_MACRO_DISEASE"},{"attr_val":"YES","sample":"TCGA-OR-A5JY-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5JY-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_MACRO"},{"attr_val":"NO","sample":"TCGA-OR-A5JY-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5JY-01","attr_id":"RACE"},{"attr_val":"YES","sample":"TCGA-OR-A5JY-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R2","sample":"TCGA-OR-A5JY-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5JY-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5JY-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5JY-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Progressive Disease","sample":"TCGA-OR-A5JY-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5JY-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5JY-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Dead","sample":"TCGA-OR-A5JY-01","attr_id":"VITAL_STATUS"},{"attr_val":"60","sample":"TCGA-OR-A5JZ-01","attr_id":"AGE"},{"attr_val":"Stage II","sample":"TCGA-OR-A5JZ-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"M0","sample":"TCGA-OR-A5JZ-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JZ-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"211","sample":"TCGA-OR-A5JZ-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-22218","sample":"TCGA-OR-A5JZ-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5JZ-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5JZ-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5JZ-01","attr_id":"DFS_STATUS"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5JZ-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-10","sample":"TCGA-OR-A5JZ-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"MALE","sample":"TCGA-OR-A5JZ-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5JZ-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"None","sample":"TCGA-OR-A5JZ-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"No","sample":"TCGA-OR-A5JZ-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5JZ-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JZ-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5JZ-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JZ-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5JZ-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2011","sample":"TCGA-OR-A5JZ-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"130","sample":"TCGA-OR-A5JZ-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5JZ-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5JZ-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"5","sample":"TCGA-OR-A5JZ-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Absent","sample":"TCGA-OR-A5JZ-01","attr_id":"MITOTIC_RATE"},{"attr_val":"NO","sample":"TCGA-OR-A5JZ-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"NA","sample":"TCGA-OR-A5JZ-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5JZ-01","attr_id":"OS_STATUS"},{"attr_val":"94CDAC79-2B4E-483A-8F17-3E0C9BE589D0","sample":"TCGA-OR-A5JZ-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"90A9556D-C417-4FDB-AE1C-7ACB9F60E444","sample":"TCGA-OR-A5JZ-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5JZ-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5JZ-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5JZ-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5JZ-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5JZ-01","attr_id":"PHARM_TX_MITOTANE_FOR_MACRO_DISEASE"},{"attr_val":"YES","sample":"TCGA-OR-A5JZ-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5JZ-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OR-A5JZ-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5JZ-01","attr_id":"RACE"},{"attr_val":"YES","sample":"TCGA-OR-A5JZ-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5JZ-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5JZ-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5JZ-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5JZ-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5JZ-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5JZ-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5JZ-01","attr_id":"VITAL_STATUS"},{"attr_val":"69","sample":"TCGA-OR-A5K0-01","attr_id":"AGE"},{"attr_val":"Stage II","sample":"TCGA-OR-A5K0-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"M0","sample":"TCGA-OR-A5K0-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5K0-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"1029","sample":"TCGA-OR-A5K0-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-25400","sample":"TCGA-OR-A5K0-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5K0-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5K0-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5K0-01","attr_id":"DFS_STATUS"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5K0-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-16","sample":"TCGA-OR-A5K0-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5K0-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5K0-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Cortisol","sample":"TCGA-OR-A5K0-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Biochemical Assessment","sample":"TCGA-OR-A5K0-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5K0-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"Yes","sample":"TCGA-OR-A5K0-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5K0-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5K0-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5K0-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5K0-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2009","sample":"TCGA-OR-A5K0-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"200","sample":"TCGA-OR-A5K0-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5K0-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5K0-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"8","sample":"TCGA-OR-A5K0-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Present","sample":"TCGA-OR-A5K0-01","attr_id":"MITOTIC_RATE"},{"attr_val":"YES","sample":"TCGA-OR-A5K0-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"NA","sample":"TCGA-OR-A5K0-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5K0-01","attr_id":"OS_STATUS"},{"attr_val":"EDC62C30-CACC-457D-96BA-D05ED35432A3","sample":"TCGA-OR-A5K0-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"4E5C6CF0-F346-4ECE-B296-0D2DB4513804","sample":"TCGA-OR-A5K0-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5K0-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5K0-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5K0-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5K0-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5K0-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5K0-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5K0-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5K0-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5K0-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5K0-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5K0-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Progressive Disease","sample":"TCGA-OR-A5K0-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5K0-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5K0-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5K0-01","attr_id":"VITAL_STATUS"},{"attr_val":"48","sample":"TCGA-OR-A5K1-01","attr_id":"AGE"},{"attr_val":"Stage II","sample":"TCGA-OR-A5K1-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"M0","sample":"TCGA-OR-A5K1-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5K1-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"2723","sample":"TCGA-OR-A5K1-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-17596","sample":"TCGA-OR-A5K1-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5K1-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5K1-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5K1-01","attr_id":"DFS_STATUS"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5K1-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-10","sample":"TCGA-OR-A5K1-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"MALE","sample":"TCGA-OR-A5K1-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5K1-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"None","sample":"TCGA-OR-A5K1-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"No","sample":"TCGA-OR-A5K1-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5K1-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5K1-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5K1-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5K1-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5K1-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2006","sample":"TCGA-OR-A5K1-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"150","sample":"TCGA-OR-A5K1-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5K1-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5K1-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"YES","sample":"TCGA-OR-A5K1-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"NA","sample":"TCGA-OR-A5K1-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5K1-01","attr_id":"OS_STATUS"},{"attr_val":"F8E77BB6-E521-4A6A-9CB4-4B58EE38CA7F","sample":"TCGA-OR-A5K1-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"54EFE89F-32E0-4E95-A841-728648D9D11E","sample":"TCGA-OR-A5K1-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5K1-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5K1-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5K1-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5K1-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5K1-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5K1-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5K1-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"RX","sample":"TCGA-OR-A5K1-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5K1-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5K1-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5K1-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Progressive Disease","sample":"TCGA-OR-A5K1-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5K1-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5K1-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5K1-01","attr_id":"VITAL_STATUS"},{"attr_val":"32","sample":"TCGA-OR-A5K2-01","attr_id":"AGE"},{"attr_val":"Stage III","sample":"TCGA-OR-A5K2-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"M0","sample":"TCGA-OR-A5K2-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5K2-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"-11970","sample":"TCGA-OR-A5K2-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"994","sample":"TCGA-OR-A5K2-01","attr_id":"DAYS_TO_DEATH"},{"attr_val":"0","sample":"TCGA-OR-A5K2-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5K2-01","attr_id":"DFS_MONTHS"},{"attr_val":"NA","sample":"TCGA-OR-A5K2-01","attr_id":"DFS_STATUS"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5K2-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-10","sample":"TCGA-OR-A5K2-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5K2-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5K2-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Androgen|Cortisol","sample":"TCGA-OR-A5K2-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5K2-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5K2-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5K2-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5K2-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5K2-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5K2-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5K2-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2010","sample":"TCGA-OR-A5K2-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"150","sample":"TCGA-OR-A5K2-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5K2-01","attr_id":"LATERALITY"},{"attr_val":"1","sample":"TCGA-OR-A5K2-01","attr_id":"LYMPH_NODES_EXAMINED"},{"attr_val":"0","sample":"TCGA-OR-A5K2-01","attr_id":"LYMPH_NODES_EXAMINED_HE_COUNT"},{"attr_val":"YES","sample":"TCGA-OR-A5K2-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"51","sample":"TCGA-OR-A5K2-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Present","sample":"TCGA-OR-A5K2-01","attr_id":"MITOTIC_RATE"},{"attr_val":"YES","sample":"TCGA-OR-A5K2-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"DECEASED","sample":"TCGA-OR-A5K2-01","attr_id":"OS_STATUS"},{"attr_val":"6D980941-219E-40A0-9B41-E84C3FB0BD1A","sample":"TCGA-OR-A5K2-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"F6CEA42D-A107-4942-B6FE-1C529D124337","sample":"TCGA-OR-A5K2-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5K2-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T4","sample":"TCGA-OR-A5K2-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5K2-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5K2-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5K2-01","attr_id":"PHARM_TX_MITOTANE_FOR_MACRO_DISEASE"},{"attr_val":"YES","sample":"TCGA-OR-A5K2-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5K2-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_PROG"},{"attr_val":"NO","sample":"TCGA-OR-A5K2-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_REC"},{"attr_val":"YES","sample":"TCGA-OR-A5K2-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5K2-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_MACRO"},{"attr_val":"NO","sample":"TCGA-OR-A5K2-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5K2-01","attr_id":"RACE"},{"attr_val":"YES","sample":"TCGA-OR-A5K2-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5K2-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5K2-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5K2-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5K2-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Progressive Disease","sample":"TCGA-OR-A5K2-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5K2-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5K2-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Dead","sample":"TCGA-OR-A5K2-01","attr_id":"VITAL_STATUS"},{"attr_val":"53","sample":"TCGA-OR-A5K3-01","attr_id":"AGE"},{"attr_val":"Stage II","sample":"TCGA-OR-A5K3-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"M0","sample":"TCGA-OR-A5K3-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5K3-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"2842","sample":"TCGA-OR-A5K3-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-19375","sample":"TCGA-OR-A5K3-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5K3-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5K3-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5K3-01","attr_id":"DFS_STATUS"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5K3-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-11","sample":"TCGA-OR-A5K3-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"MALE","sample":"TCGA-OR-A5K3-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical Carcinoma- Oncocytic Type","sample":"TCGA-OR-A5K3-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"None","sample":"TCGA-OR-A5K3-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"No","sample":"TCGA-OR-A5K3-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5K3-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5K3-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5K3-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5K3-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5K3-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2005","sample":"TCGA-OR-A5K3-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"110","sample":"TCGA-OR-A5K3-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5K3-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5K3-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"NO","sample":"TCGA-OR-A5K3-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"NA","sample":"TCGA-OR-A5K3-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5K3-01","attr_id":"OS_STATUS"},{"attr_val":"C72B973B-4719-46AB-AC99-05D14088D3BC","sample":"TCGA-OR-A5K3-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"718C16E9-A099-4F21-A48E-A97B464A9422","sample":"TCGA-OR-A5K3-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5K3-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5K3-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5K3-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5K3-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5K3-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5K3-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5K3-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5K3-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5K3-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5K3-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5K3-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Complete Remission\/Response","sample":"TCGA-OR-A5K3-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5K3-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5K3-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5K3-01","attr_id":"VITAL_STATUS"},{"attr_val":"64","sample":"TCGA-OR-A5K4-01","attr_id":"AGE"},{"attr_val":"Stage III","sample":"TCGA-OR-A5K4-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"M0","sample":"TCGA-OR-A5K4-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5K4-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"528","sample":"TCGA-OR-A5K4-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-23481","sample":"TCGA-OR-A5K4-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5K4-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5K4-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5K4-01","attr_id":"DFS_STATUS"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5K4-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-11","sample":"TCGA-OR-A5K4-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5K4-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5K4-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"None","sample":"TCGA-OR-A5K4-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"No","sample":"TCGA-OR-A5K4-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5K4-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5K4-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5K4-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5K4-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5K4-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2011","sample":"TCGA-OR-A5K4-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"190","sample":"TCGA-OR-A5K4-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5K4-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5K4-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"2","sample":"TCGA-OR-A5K4-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Absent","sample":"TCGA-OR-A5K4-01","attr_id":"MITOTIC_RATE"},{"attr_val":"NO","sample":"TCGA-OR-A5K4-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"NA","sample":"TCGA-OR-A5K4-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5K4-01","attr_id":"OS_STATUS"},{"attr_val":"70F1569E-F8F5-4F1D-BF18-D0586B29077D","sample":"TCGA-OR-A5K4-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"15A731FD-6B89-450D-A02B-A01DA759340A","sample":"TCGA-OR-A5K4-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5K4-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T4","sample":"TCGA-OR-A5K4-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5K4-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5K4-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5K4-01","attr_id":"PHARM_TX_MITOTANE_FOR_MACRO_DISEASE"},{"attr_val":"YES","sample":"TCGA-OR-A5K4-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5K4-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OR-A5K4-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5K4-01","attr_id":"RACE"},{"attr_val":"YES","sample":"TCGA-OR-A5K4-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R1","sample":"TCGA-OR-A5K4-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5K4-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5K4-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5K4-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Complete Remission\/Response","sample":"TCGA-OR-A5K4-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5K4-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5K4-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5K4-01","attr_id":"VITAL_STATUS"},{"attr_val":"59","sample":"TCGA-OR-A5K5-01","attr_id":"AGE"},{"attr_val":"Stage III","sample":"TCGA-OR-A5K5-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"M0","sample":"TCGA-OR-A5K5-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5K5-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"253","sample":"TCGA-OR-A5K5-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-21907","sample":"TCGA-OR-A5K5-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5K5-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5K5-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5K5-01","attr_id":"DFS_STATUS"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5K5-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-11","sample":"TCGA-OR-A5K5-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5K5-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5K5-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Androgen|Cortisol","sample":"TCGA-OR-A5K5-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5K5-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5K5-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5K5-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5K5-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5K5-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5K5-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5K5-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2012","sample":"TCGA-OR-A5K5-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"120","sample":"TCGA-OR-A5K5-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5K5-01","attr_id":"LATERALITY"},{"attr_val":"20","sample":"TCGA-OR-A5K5-01","attr_id":"LYMPH_NODES_EXAMINED"},{"attr_val":"0","sample":"TCGA-OR-A5K5-01","attr_id":"LYMPH_NODES_EXAMINED_HE_COUNT"},{"attr_val":"YES","sample":"TCGA-OR-A5K5-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"31","sample":"TCGA-OR-A5K5-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Present","sample":"TCGA-OR-A5K5-01","attr_id":"MITOTIC_RATE"},{"attr_val":"YES","sample":"TCGA-OR-A5K5-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"NA","sample":"TCGA-OR-A5K5-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5K5-01","attr_id":"OS_STATUS"},{"attr_val":"CF332DAA-F335-4AF1-81DE-CBFDAFB0F764","sample":"TCGA-OR-A5K5-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"6EA3FB77-3DD4-43C8-8C39-CA8755EBC50C","sample":"TCGA-OR-A5K5-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5K5-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T3","sample":"TCGA-OR-A5K5-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5K5-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5K5-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5K5-01","attr_id":"PHARM_TX_MITOTANE_FOR_MACRO_DISEASE"},{"attr_val":"YES","sample":"TCGA-OR-A5K5-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5K5-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_REC"},{"attr_val":"YES","sample":"TCGA-OR-A5K5-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OR-A5K5-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5K5-01","attr_id":"RACE"},{"attr_val":"YES","sample":"TCGA-OR-A5K5-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5K5-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5K5-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5K5-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5K5-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Progressive Disease","sample":"TCGA-OR-A5K5-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5K5-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5K5-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5K5-01","attr_id":"VITAL_STATUS"},{"attr_val":"56","sample":"TCGA-OR-A5K6-01","attr_id":"AGE"},{"attr_val":"Stage II","sample":"TCGA-OR-A5K6-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Present","sample":"TCGA-OR-A5K6-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5K6-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5K6-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5K6-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"1130","sample":"TCGA-OR-A5K6-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-20657","sample":"TCGA-OR-A5K6-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5K6-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5K6-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5K6-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Absent","sample":"TCGA-OR-A5K6-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"NOT HISPANIC OR LATINO","sample":"TCGA-OR-A5K6-01","attr_id":"ETHNICITY"},{"attr_val":"2013-10-8","sample":"TCGA-OR-A5K6-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5K6-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5K6-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Cortisol","sample":"TCGA-OR-A5K6-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5K6-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5K6-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5K6-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5K6-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5K6-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5K6-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5K6-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2010","sample":"TCGA-OR-A5K6-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"120","sample":"TCGA-OR-A5K6-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5K6-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5K6-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"7","sample":"TCGA-OR-A5K6-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Present","sample":"TCGA-OR-A5K6-01","attr_id":"MITOTIC_RATE"},{"attr_val":"YES","sample":"TCGA-OR-A5K6-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5K6-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5K6-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5K6-01","attr_id":"OS_STATUS"},{"attr_val":"28153E3E-8515-4852-AAA0-247F86399F27","sample":"TCGA-OR-A5K6-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"CB9B68D7-762B-4828-9479-4ECFE346AB5C","sample":"TCGA-OR-A5K6-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5K6-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5K6-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5K6-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5K6-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5K6-01","attr_id":"PHARM_TX_MITOTANE_FOR_MACRO_DISEASE"},{"attr_val":"YES","sample":"TCGA-OR-A5K6-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"YES","sample":"TCGA-OR-A5K6-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_PROG"},{"attr_val":"NO","sample":"TCGA-OR-A5K6-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_REC"},{"attr_val":"NO","sample":"TCGA-OR-A5K6-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"YES","sample":"TCGA-OR-A5K6-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_MACRO"},{"attr_val":"YES","sample":"TCGA-OR-A5K6-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5K6-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5K6-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5K6-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"NO","sample":"TCGA-OR-A5K6-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5K6-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5K6-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Complete Remission\/Response","sample":"TCGA-OR-A5K6-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5K6-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5K6-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5K6-01","attr_id":"VITAL_STATUS"},{"attr_val":"61","sample":"TCGA-OR-A5K9-01","attr_id":"AGE"},{"attr_val":"Stage II","sample":"TCGA-OR-A5K9-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"M0","sample":"TCGA-OR-A5K9-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5K9-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"-22596","sample":"TCGA-OR-A5K9-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"344","sample":"TCGA-OR-A5K9-01","attr_id":"DAYS_TO_DEATH"},{"attr_val":"0","sample":"TCGA-OR-A5K9-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5K9-01","attr_id":"DFS_MONTHS"},{"attr_val":"NA","sample":"TCGA-OR-A5K9-01","attr_id":"DFS_STATUS"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5K9-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-11","sample":"TCGA-OR-A5K9-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5K9-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5K9-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Androgen|Cortisol","sample":"TCGA-OR-A5K9-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5K9-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5K9-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5K9-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5K9-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5K9-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5K9-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5K9-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2002","sample":"TCGA-OR-A5K9-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"130","sample":"TCGA-OR-A5K9-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5K9-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5K9-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"YES","sample":"TCGA-OR-A5K9-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"DECEASED","sample":"TCGA-OR-A5K9-01","attr_id":"OS_STATUS"},{"attr_val":"D890CBF7-41D8-4992-99C2-24C60C77B156","sample":"TCGA-OR-A5K9-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"EAC92541-2274-4FB8-B56B-657413EDF0F9","sample":"TCGA-OR-A5K9-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5K9-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5K9-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5K9-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5K9-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5K9-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5K9-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OR-A5K9-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5K9-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5K9-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5K9-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5K9-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5K9-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5K9-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5K9-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5K9-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Dead","sample":"TCGA-OR-A5K9-01","attr_id":"VITAL_STATUS"},{"attr_val":"39","sample":"TCGA-OR-A5KO-01","attr_id":"AGE"},{"attr_val":"Stage IV","sample":"TCGA-OR-A5KO-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Present","sample":"TCGA-OR-A5KO-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M1","sample":"TCGA-OR-A5KO-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5KO-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5KO-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"1414","sample":"TCGA-OR-A5KO-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-14606","sample":"TCGA-OR-A5KO-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5KO-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5KO-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5KO-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Present","sample":"TCGA-OR-A5KO-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"NOT HISPANIC OR LATINO","sample":"TCGA-OR-A5KO-01","attr_id":"ETHNICITY"},{"attr_val":"2013-11-5","sample":"TCGA-OR-A5KO-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5KO-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5KO-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Cortisol","sample":"TCGA-OR-A5KO-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5KO-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5KO-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5KO-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5KO-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5KO-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5KO-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5KO-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2009","sample":"TCGA-OR-A5KO-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"80","sample":"TCGA-OR-A5KO-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5KO-01","attr_id":"LATERALITY"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5KO-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"Mitotic Rate > 5\/50 HPF Present","sample":"TCGA-OR-A5KO-01","attr_id":"MITOTIC_RATE"},{"attr_val":"YES","sample":"TCGA-OR-A5KO-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5KO-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5KO-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5KO-01","attr_id":"OS_STATUS"},{"attr_val":"B4B41A43-EE45-4AA3-ABF0-100DB752A6AC","sample":"TCGA-OR-A5KO-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"B9C848FD-453C-4A56-B625-C4C680790D6A","sample":"TCGA-OR-A5KO-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5KO-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T4","sample":"TCGA-OR-A5KO-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5KO-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5KO-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5KO-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5KO-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OR-A5KO-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5KO-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5KO-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5KO-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5KO-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5KO-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5KO-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Progressive Disease","sample":"TCGA-OR-A5KO-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5KO-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5KO-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5KO-01","attr_id":"VITAL_STATUS"},{"attr_val":"44","sample":"TCGA-OR-A5KT-01","attr_id":"AGE"},{"attr_val":"Stage I","sample":"TCGA-OR-A5KT-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Absent","sample":"TCGA-OR-A5KT-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5KT-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5KT-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5KT-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"2673","sample":"TCGA-OR-A5KT-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-16217","sample":"TCGA-OR-A5KT-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5KT-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5KT-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5KT-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Absent","sample":"TCGA-OR-A5KT-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"NOT HISPANIC OR LATINO","sample":"TCGA-OR-A5KT-01","attr_id":"ETHNICITY"},{"attr_val":"2014-4-2","sample":"TCGA-OR-A5KT-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5KT-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5KT-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Androgen|Cortisol","sample":"TCGA-OR-A5KT-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5KT-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5KT-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5KT-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5KT-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5KT-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5KT-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5KT-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2006","sample":"TCGA-OR-A5KT-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"80","sample":"TCGA-OR-A5KT-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5KT-01","attr_id":"LATERALITY"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5KT-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"1","sample":"TCGA-OR-A5KT-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Absent","sample":"TCGA-OR-A5KT-01","attr_id":"MITOTIC_RATE"},{"attr_val":"YES","sample":"TCGA-OR-A5KT-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Absent","sample":"TCGA-OR-A5KT-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5KT-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5KT-01","attr_id":"OS_STATUS"},{"attr_val":"DE7F06AA-9638-4389-AC8E-711ADFA0F2A5","sample":"TCGA-OR-A5KT-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"7BE65565-0C63-466C-AE5D-A9B47BB354C9","sample":"TCGA-OR-A5KT-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5KT-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T1","sample":"TCGA-OR-A5KT-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5KT-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5KT-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5KT-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5KT-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5KT-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5KT-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5KT-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5KT-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5KT-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Complete Remission\/Response","sample":"TCGA-OR-A5KT-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5KT-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5KT-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5KT-01","attr_id":"VITAL_STATUS"},{"attr_val":"37","sample":"TCGA-OR-A5KU-01","attr_id":"AGE"},{"attr_val":"Stage II","sample":"TCGA-OR-A5KU-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Absent","sample":"TCGA-OR-A5KU-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5KU-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5KU-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5KU-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"4673","sample":"TCGA-OR-A5KU-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-13559","sample":"TCGA-OR-A5KU-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5KU-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5KU-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5KU-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Absent","sample":"TCGA-OR-A5KU-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"NOT HISPANIC OR LATINO","sample":"TCGA-OR-A5KU-01","attr_id":"ETHNICITY"},{"attr_val":"2013-11-5","sample":"TCGA-OR-A5KU-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5KU-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5KU-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Mineralocorticoids","sample":"TCGA-OR-A5KU-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5KU-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5KU-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5KU-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5KU-01","attr_id":"ICD_10"},{"attr_val":"8370\/1","sample":"TCGA-OR-A5KU-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5KU-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5KU-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2000","sample":"TCGA-OR-A5KU-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"70","sample":"TCGA-OR-A5KU-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5KU-01","attr_id":"LATERALITY"},{"attr_val":"1","sample":"TCGA-OR-A5KU-01","attr_id":"LYMPH_NODES_EXAMINED"},{"attr_val":"0","sample":"TCGA-OR-A5KU-01","attr_id":"LYMPH_NODES_EXAMINED_HE_COUNT"},{"attr_val":"YES","sample":"TCGA-OR-A5KU-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"Mitotic Rate > 5\/50 HPF Absent","sample":"TCGA-OR-A5KU-01","attr_id":"MITOTIC_RATE"},{"attr_val":"NO","sample":"TCGA-OR-A5KU-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Absent","sample":"TCGA-OR-A5KU-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5KU-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5KU-01","attr_id":"OS_STATUS"},{"attr_val":"424A497A-48B9-4507-B234-C4FD08C8ACAD","sample":"TCGA-OR-A5KU-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"F9F537ED-3066-4E99-B6D1-112D6C4551F0","sample":"TCGA-OR-A5KU-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5KU-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5KU-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5KU-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5KU-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5KU-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5KU-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_REC"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5KU-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OR-A5KU-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5KU-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5KU-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5KU-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5KU-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5KU-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5KU-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Complete Remission\/Response","sample":"TCGA-OR-A5KU-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5KU-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5KU-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5KU-01","attr_id":"VITAL_STATUS"},{"attr_val":"17","sample":"TCGA-OR-A5KV-01","attr_id":"AGE"},{"attr_val":"Stage III","sample":"TCGA-OR-A5KV-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Present","sample":"TCGA-OR-A5KV-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5KV-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5KV-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Absent","sample":"TCGA-OR-A5KV-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"3659","sample":"TCGA-OR-A5KV-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-6250","sample":"TCGA-OR-A5KV-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5KV-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5KV-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5KV-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Absent","sample":"TCGA-OR-A5KV-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"NOT HISPANIC OR LATINO","sample":"TCGA-OR-A5KV-01","attr_id":"ETHNICITY"},{"attr_val":"2013-11-5","sample":"TCGA-OR-A5KV-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5KV-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5KV-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Androgen|Cortisol","sample":"TCGA-OR-A5KV-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Biochemical Assessment","sample":"TCGA-OR-A5KV-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5KV-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5KV-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5KV-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5KV-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5KV-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5KV-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2003","sample":"TCGA-OR-A5KV-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"50","sample":"TCGA-OR-A5KV-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5KV-01","attr_id":"LATERALITY"},{"attr_val":"1","sample":"TCGA-OR-A5KV-01","attr_id":"LYMPH_NODES_EXAMINED"},{"attr_val":"1","sample":"TCGA-OR-A5KV-01","attr_id":"LYMPH_NODES_EXAMINED_HE_COUNT"},{"attr_val":"YES","sample":"TCGA-OR-A5KV-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"Mitotic Rate > 5\/50 HPF Absent","sample":"TCGA-OR-A5KV-01","attr_id":"MITOTIC_RATE"},{"attr_val":"YES","sample":"TCGA-OR-A5KV-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5KV-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5KV-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5KV-01","attr_id":"OS_STATUS"},{"attr_val":"202F7A77-9E5A-4F12-8FFE-78AE5527A746","sample":"TCGA-OR-A5KV-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"D85CC5BA-0A85-4BCB-8088-9EBA37211501","sample":"TCGA-OR-A5KV-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N1","sample":"TCGA-OR-A5KV-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5KV-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5KV-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5KV-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5KV-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5KV-01","attr_id":"RACE"},{"attr_val":"YES","sample":"TCGA-OR-A5KV-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5KV-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5KV-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5KV-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5KV-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Complete Remission\/Response","sample":"TCGA-OR-A5KV-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5KV-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5KV-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5KV-01","attr_id":"VITAL_STATUS"},{"attr_val":"55","sample":"TCGA-OR-A5KW-01","attr_id":"AGE"},{"attr_val":"Stage III","sample":"TCGA-OR-A5KW-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"M0","sample":"TCGA-OR-A5KW-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5KW-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"1525","sample":"TCGA-OR-A5KW-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-20328","sample":"TCGA-OR-A5KW-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5KW-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5KW-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5KW-01","attr_id":"DFS_STATUS"},{"attr_val":"NOT HISPANIC OR LATINO","sample":"TCGA-OR-A5KW-01","attr_id":"ETHNICITY"},{"attr_val":"2013-11-7","sample":"TCGA-OR-A5KW-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5KW-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5KW-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Androgen|Cortisol","sample":"TCGA-OR-A5KW-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5KW-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5KW-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5KW-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5KW-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5KW-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5KW-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5KW-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2009","sample":"TCGA-OR-A5KW-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"230","sample":"TCGA-OR-A5KW-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5KW-01","attr_id":"LATERALITY"},{"attr_val":"9","sample":"TCGA-OR-A5KW-01","attr_id":"LYMPH_NODES_EXAMINED"},{"attr_val":"8","sample":"TCGA-OR-A5KW-01","attr_id":"LYMPH_NODES_EXAMINED_HE_COUNT"},{"attr_val":"YES","sample":"TCGA-OR-A5KW-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"10","sample":"TCGA-OR-A5KW-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"NO","sample":"TCGA-OR-A5KW-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"NA","sample":"TCGA-OR-A5KW-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5KW-01","attr_id":"OS_STATUS"},{"attr_val":"69F4F19C-08C8-4001-92A8-FED155C3B4FE","sample":"TCGA-OR-A5KW-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"751F5B53-9186-4602-B824-8593E63EAC3F","sample":"TCGA-OR-A5KW-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N1","sample":"TCGA-OR-A5KW-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5KW-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5KW-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5KW-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5KW-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5KW-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_REC"},{"attr_val":"YES","sample":"TCGA-OR-A5KW-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OR-A5KW-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5KW-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5KW-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5KW-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5KW-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5KW-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5KW-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Complete Remission\/Response","sample":"TCGA-OR-A5KW-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5KW-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5KW-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5KW-01","attr_id":"VITAL_STATUS"},{"attr_val":"25","sample":"TCGA-OR-A5KX-01","attr_id":"AGE"},{"attr_val":"Stage III","sample":"TCGA-OR-A5KX-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Absent","sample":"TCGA-OR-A5KX-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5KX-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5KX-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5KX-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"1091","sample":"TCGA-OR-A5KX-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-9298","sample":"TCGA-OR-A5KX-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5KX-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5KX-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5KX-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Present","sample":"TCGA-OR-A5KX-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"NOT HISPANIC OR LATINO","sample":"TCGA-OR-A5KX-01","attr_id":"ETHNICITY"},{"attr_val":"2013-11-6","sample":"TCGA-OR-A5KX-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5KX-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5KX-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5KX-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"No","sample":"TCGA-OR-A5KX-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5KX-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5KX-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5KX-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5KX-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5KX-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2010","sample":"TCGA-OR-A5KX-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"190","sample":"TCGA-OR-A5KX-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5KX-01","attr_id":"LATERALITY"},{"attr_val":"YES","sample":"TCGA-OR-A5KX-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"Mitotic Rate > 5\/50 HPF Present","sample":"TCGA-OR-A5KX-01","attr_id":"MITOTIC_RATE"},{"attr_val":"YES","sample":"TCGA-OR-A5KX-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5KX-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5KX-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5KX-01","attr_id":"OS_STATUS"},{"attr_val":"33C02ECE-911B-4F45-B410-9DF07E9B189E","sample":"TCGA-OR-A5KX-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"02EBE0C2-AE20-4F08-81E7-3EC45E12C0F4","sample":"TCGA-OR-A5KX-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N1","sample":"TCGA-OR-A5KX-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5KX-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5KX-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5KX-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5KX-01","attr_id":"PHARM_TX_MITOTANE_FOR_MACRO_DISEASE"},{"attr_val":"YES","sample":"TCGA-OR-A5KX-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5KX-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OR-A5KX-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5KX-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5KX-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5KX-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5KX-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5KX-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5KX-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Progressive Disease","sample":"TCGA-OR-A5KX-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5KX-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5KX-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5KX-01","attr_id":"VITAL_STATUS"},{"attr_val":"23","sample":"TCGA-OR-A5KY-01","attr_id":"AGE"},{"attr_val":"Stage IV","sample":"TCGA-OR-A5KY-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Present","sample":"TCGA-OR-A5KY-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M1","sample":"TCGA-OR-A5KY-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5KY-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5KY-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"-8745","sample":"TCGA-OR-A5KY-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"391","sample":"TCGA-OR-A5KY-01","attr_id":"DAYS_TO_DEATH"},{"attr_val":"0","sample":"TCGA-OR-A5KY-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5KY-01","attr_id":"DFS_MONTHS"},{"attr_val":"NA","sample":"TCGA-OR-A5KY-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Absent","sample":"TCGA-OR-A5KY-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"NOT HISPANIC OR LATINO","sample":"TCGA-OR-A5KY-01","attr_id":"ETHNICITY"},{"attr_val":"2013-11-5","sample":"TCGA-OR-A5KY-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5KY-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5KY-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Androgen|Cortisol","sample":"TCGA-OR-A5KY-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5KY-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5KY-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5KY-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5KY-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5KY-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5KY-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5KY-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2010","sample":"TCGA-OR-A5KY-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"120","sample":"TCGA-OR-A5KY-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5KY-01","attr_id":"LATERALITY"},{"attr_val":"52","sample":"TCGA-OR-A5KY-01","attr_id":"LYMPH_NODES_EXAMINED"},{"attr_val":"52","sample":"TCGA-OR-A5KY-01","attr_id":"LYMPH_NODES_EXAMINED_HE_COUNT"},{"attr_val":"YES","sample":"TCGA-OR-A5KY-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"5","sample":"TCGA-OR-A5KY-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Absent","sample":"TCGA-OR-A5KY-01","attr_id":"MITOTIC_RATE"},{"attr_val":"YES","sample":"TCGA-OR-A5KY-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Absent","sample":"TCGA-OR-A5KY-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"DECEASED","sample":"TCGA-OR-A5KY-01","attr_id":"OS_STATUS"},{"attr_val":"5F461197-15ED-43CF-9331-9E0EFC4622A4","sample":"TCGA-OR-A5KY-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"23328F06-11F8-4D12-BA95-D5CC9AEFE22A","sample":"TCGA-OR-A5KY-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N1","sample":"TCGA-OR-A5KY-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T4","sample":"TCGA-OR-A5KY-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5KY-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5KY-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5KY-01","attr_id":"PHARM_TX_MITOTANE_FOR_MACRO_DISEASE"},{"attr_val":"YES","sample":"TCGA-OR-A5KY-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5KY-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_PROG"},{"attr_val":"YES","sample":"TCGA-OR-A5KY-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_MACRO"},{"attr_val":"NO","sample":"TCGA-OR-A5KY-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5KY-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5KY-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R2","sample":"TCGA-OR-A5KY-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5KY-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5KY-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5KY-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Progressive Disease","sample":"TCGA-OR-A5KY-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5KY-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5KY-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Dead","sample":"TCGA-OR-A5KY-01","attr_id":"VITAL_STATUS"},{"attr_val":"42","sample":"TCGA-OR-A5KZ-01","attr_id":"AGE"},{"attr_val":"Stage II","sample":"TCGA-OR-A5KZ-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Absent","sample":"TCGA-OR-A5KZ-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5KZ-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5KZ-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5KZ-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"-15594","sample":"TCGA-OR-A5KZ-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"125","sample":"TCGA-OR-A5KZ-01","attr_id":"DAYS_TO_DEATH"},{"attr_val":"0","sample":"TCGA-OR-A5KZ-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5KZ-01","attr_id":"DFS_MONTHS"},{"attr_val":"NA","sample":"TCGA-OR-A5KZ-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Present","sample":"TCGA-OR-A5KZ-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"NOT HISPANIC OR LATINO","sample":"TCGA-OR-A5KZ-01","attr_id":"ETHNICITY"},{"attr_val":"2013-11-7","sample":"TCGA-OR-A5KZ-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"MALE","sample":"TCGA-OR-A5KZ-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5KZ-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Cortisol","sample":"TCGA-OR-A5KZ-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5KZ-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5KZ-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5KZ-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5KZ-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5KZ-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5KZ-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5KZ-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2012","sample":"TCGA-OR-A5KZ-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"120","sample":"TCGA-OR-A5KZ-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5KZ-01","attr_id":"LATERALITY"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5KZ-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"Mitotic Rate > 5\/50 HPF Present","sample":"TCGA-OR-A5KZ-01","attr_id":"MITOTIC_RATE"},{"attr_val":"YES","sample":"TCGA-OR-A5KZ-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5KZ-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"DECEASED","sample":"TCGA-OR-A5KZ-01","attr_id":"OS_STATUS"},{"attr_val":"99F86B57-3894-45C5-BFBE-C757C69A3050","sample":"TCGA-OR-A5KZ-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"22298C81-A72D-4E22-99DD-6541FB0953A4","sample":"TCGA-OR-A5KZ-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5KZ-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5KZ-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5KZ-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5KZ-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5KZ-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5KZ-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OR-A5KZ-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5KZ-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5KZ-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"RX","sample":"TCGA-OR-A5KZ-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5KZ-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5KZ-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5KZ-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Progressive Disease","sample":"TCGA-OR-A5KZ-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OR-A5KZ-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5KZ-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Dead","sample":"TCGA-OR-A5KZ-01","attr_id":"VITAL_STATUS"},{"attr_val":"67","sample":"TCGA-OR-A5L3-01","attr_id":"AGE"},{"attr_val":"Stage I","sample":"TCGA-OR-A5L3-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Absent","sample":"TCGA-OR-A5L3-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5L3-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5L3-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Absent","sample":"TCGA-OR-A5L3-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"3897","sample":"TCGA-OR-A5L3-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-24763","sample":"TCGA-OR-A5L3-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5L3-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5L3-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5L3-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Absent","sample":"TCGA-OR-A5L3-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"NOT HISPANIC OR LATINO","sample":"TCGA-OR-A5L3-01","attr_id":"ETHNICITY"},{"attr_val":"2013-11-5","sample":"TCGA-OR-A5L3-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5L3-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5L3-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Cortisol","sample":"TCGA-OR-A5L3-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5L3-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5L3-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5L3-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5L3-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5L3-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5L3-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5L3-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2000","sample":"TCGA-OR-A5L3-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"70","sample":"TCGA-OR-A5L3-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5L3-01","attr_id":"LATERALITY"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5L3-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"Mitotic Rate > 5\/50 HPF Absent","sample":"TCGA-OR-A5L3-01","attr_id":"MITOTIC_RATE"},{"attr_val":"NO","sample":"TCGA-OR-A5L3-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5L3-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5L3-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5L3-01","attr_id":"OS_STATUS"},{"attr_val":"A9A57127-94D3-425F-A4C5-5CBCF24A9A35","sample":"TCGA-OR-A5L3-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"FE1CF238-753C-4DF4-A083-74DDC753DF45","sample":"TCGA-OR-A5L3-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5L3-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T1","sample":"TCGA-OR-A5L3-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5L3-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5L3-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5L3-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5L3-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5L3-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5L3-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5L3-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5L3-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5L3-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Complete Remission\/Response","sample":"TCGA-OR-A5L3-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5L3-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5L3-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5L3-01","attr_id":"VITAL_STATUS"},{"attr_val":"77","sample":"TCGA-OR-A5L5-01","attr_id":"AGE"},{"attr_val":"Stage I","sample":"TCGA-OR-A5L5-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Absent","sample":"TCGA-OR-A5L5-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5L5-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5L5-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Absent","sample":"TCGA-OR-A5L5-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"840","sample":"TCGA-OR-A5L5-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-28270","sample":"TCGA-OR-A5L5-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5L5-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5L5-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5L5-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Absent","sample":"TCGA-OR-A5L5-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"NOT HISPANIC OR LATINO","sample":"TCGA-OR-A5L5-01","attr_id":"ETHNICITY"},{"attr_val":"2013-11-6","sample":"TCGA-OR-A5L5-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5L5-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5L5-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Androgen|Estrogen","sample":"TCGA-OR-A5L5-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Biochemical Assessment","sample":"TCGA-OR-A5L5-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5L5-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"Yes","sample":"TCGA-OR-A5L5-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5L5-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5L5-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5L5-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5L5-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2010","sample":"TCGA-OR-A5L5-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"70","sample":"TCGA-OR-A5L5-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5L5-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5L5-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"15","sample":"TCGA-OR-A5L5-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Present","sample":"TCGA-OR-A5L5-01","attr_id":"MITOTIC_RATE"},{"attr_val":"NO","sample":"TCGA-OR-A5L5-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5L5-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5L5-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5L5-01","attr_id":"OS_STATUS"},{"attr_val":"2F04E760-8A64-49F2-A1D6-3D390604745C","sample":"TCGA-OR-A5L5-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"A1989B2E-FB1F-420A-BF11-2C79F3E81884","sample":"TCGA-OR-A5L5-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5L5-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T1","sample":"TCGA-OR-A5L5-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5L5-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5L5-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5L5-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5L5-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5L5-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5L5-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5L5-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5L5-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5L5-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Complete Remission\/Response","sample":"TCGA-OR-A5L5-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5L5-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5L5-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5L5-01","attr_id":"VITAL_STATUS"},{"attr_val":"60","sample":"TCGA-OR-A5L6-01","attr_id":"AGE"},{"attr_val":"Stage II","sample":"TCGA-OR-A5L6-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Absent","sample":"TCGA-OR-A5L6-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5L6-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5L6-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5L6-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"628","sample":"TCGA-OR-A5L6-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-22057","sample":"TCGA-OR-A5L6-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5L6-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5L6-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5L6-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Present","sample":"TCGA-OR-A5L6-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"NOT HISPANIC OR LATINO","sample":"TCGA-OR-A5L6-01","attr_id":"ETHNICITY"},{"attr_val":"2013-11-5","sample":"TCGA-OR-A5L6-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"MALE","sample":"TCGA-OR-A5L6-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5L6-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Androgen","sample":"TCGA-OR-A5L6-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Biochemical Assessment","sample":"TCGA-OR-A5L6-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5L6-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5L6-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5L6-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5L6-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5L6-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5L6-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2011","sample":"TCGA-OR-A5L6-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"80","sample":"TCGA-OR-A5L6-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5L6-01","attr_id":"LATERALITY"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5L6-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"23","sample":"TCGA-OR-A5L6-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Present","sample":"TCGA-OR-A5L6-01","attr_id":"MITOTIC_RATE"},{"attr_val":"NO","sample":"TCGA-OR-A5L6-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5L6-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5L6-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5L6-01","attr_id":"OS_STATUS"},{"attr_val":"F13A3D5E-7F8E-4ACB-AD46-F6380A9443E8","sample":"TCGA-OR-A5L6-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"6104CA0C-86CD-46C9-A111-0024A75FB727","sample":"TCGA-OR-A5L6-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5L6-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5L6-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5L6-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5L6-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5L6-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5L6-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5L6-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5L6-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5L6-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5L6-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5L6-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Complete Remission\/Response","sample":"TCGA-OR-A5L6-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5L6-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5L6-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5L6-01","attr_id":"VITAL_STATUS"},{"attr_val":"36","sample":"TCGA-OR-A5L8-01","attr_id":"AGE"},{"attr_val":"Stage II","sample":"TCGA-OR-A5L8-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Absent","sample":"TCGA-OR-A5L8-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5L8-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5L8-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5L8-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"555","sample":"TCGA-OR-A5L8-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-13472","sample":"TCGA-OR-A5L8-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5L8-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5L8-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5L8-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Absent","sample":"TCGA-OR-A5L8-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"NOT HISPANIC OR LATINO","sample":"TCGA-OR-A5L8-01","attr_id":"ETHNICITY"},{"attr_val":"2013-11-4","sample":"TCGA-OR-A5L8-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5L8-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5L8-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"Mineralocorticoids|Cortisol","sample":"TCGA-OR-A5L8-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"Both Clinical and Biochemical Assessments","sample":"TCGA-OR-A5L8-01","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"attr_val":"No","sample":"TCGA-OR-A5L8-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5L8-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5L8-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5L8-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5L8-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5L8-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2011","sample":"TCGA-OR-A5L8-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"70","sample":"TCGA-OR-A5L8-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5L8-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5L8-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"Mitotic Rate > 5\/50 HPF Absent","sample":"TCGA-OR-A5L8-01","attr_id":"MITOTIC_RATE"},{"attr_val":"NO","sample":"TCGA-OR-A5L8-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Absent","sample":"TCGA-OR-A5L8-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5L8-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5L8-01","attr_id":"OS_STATUS"},{"attr_val":"5E086192-AB74-4AA3-BF6B-B34AB19995DB","sample":"TCGA-OR-A5L8-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"C4BBFD0B-83D0-47C8-9662-13691FE6D820","sample":"TCGA-OR-A5L8-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5L8-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5L8-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5L8-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5L8-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5L8-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5L8-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_REC"},{"attr_val":"YES","sample":"TCGA-OR-A5L8-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OR-A5L8-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5L8-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5L8-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5L8-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5L8-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5L8-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5L8-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5L8-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5L8-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5L8-01","attr_id":"VITAL_STATUS"},{"attr_val":"62","sample":"TCGA-OR-A5LK-01","attr_id":"AGE"},{"attr_val":"Stage II","sample":"TCGA-OR-A5LK-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"M0","sample":"TCGA-OR-A5LK-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5LK-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"2222","sample":"TCGA-OR-A5LK-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-22919","sample":"TCGA-OR-A5LK-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5LK-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5LK-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5LK-01","attr_id":"DFS_STATUS"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5LK-01","attr_id":"ETHNICITY"},{"attr_val":"2013-11-27","sample":"TCGA-OR-A5LK-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"MALE","sample":"TCGA-OR-A5LK-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical Carcinoma- Oncocytic Type","sample":"TCGA-OR-A5LK-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"None","sample":"TCGA-OR-A5LK-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"No","sample":"TCGA-OR-A5LK-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5LK-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5LK-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5LK-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5LK-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5LK-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2007","sample":"TCGA-OR-A5LK-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"120","sample":"TCGA-OR-A5LK-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5LK-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-OR-A5LK-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"7","sample":"TCGA-OR-A5LK-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"NO","sample":"TCGA-OR-A5LK-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"NA","sample":"TCGA-OR-A5LK-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5LK-01","attr_id":"OS_STATUS"},{"attr_val":"9C87DCEE-D422-4DF1-82E1-3FA201473E31","sample":"TCGA-OR-A5LK-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"4917D13C-6355-4E4B-8189-FE4443313F53","sample":"TCGA-OR-A5LK-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5LK-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5LK-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5LK-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5LK-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OR-A5LK-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5LK-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_REC"},{"attr_val":"YES","sample":"TCGA-OR-A5LK-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OR-A5LK-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_MACRO"},{"attr_val":"NO","sample":"TCGA-OR-A5LK-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5LK-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5LK-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5LK-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5LK-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5LK-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5LK-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Complete Remission\/Response","sample":"TCGA-OR-A5LK-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5LK-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5LK-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5LK-01","attr_id":"VITAL_STATUS"},{"attr_val":"31","sample":"TCGA-OR-A5LN-01","attr_id":"AGE"},{"attr_val":"Stage II","sample":"TCGA-OR-A5LN-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Present","sample":"TCGA-OR-A5LN-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5LN-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5LN-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5LN-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"1916","sample":"TCGA-OR-A5LN-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-11414","sample":"TCGA-OR-A5LN-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5LN-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5LN-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5LN-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Present","sample":"TCGA-OR-A5LN-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5LN-01","attr_id":"ETHNICITY"},{"attr_val":"2013-11-27","sample":"TCGA-OR-A5LN-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5LN-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OR-A5LN-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"None","sample":"TCGA-OR-A5LN-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"No","sample":"TCGA-OR-A5LN-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5LN-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5LN-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5LN-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5LN-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5LN-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2008","sample":"TCGA-OR-A5LN-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"120","sample":"TCGA-OR-A5LN-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-OR-A5LN-01","attr_id":"LATERALITY"},{"attr_val":"10","sample":"TCGA-OR-A5LN-01","attr_id":"LYMPH_NODES_EXAMINED"},{"attr_val":"0","sample":"TCGA-OR-A5LN-01","attr_id":"LYMPH_NODES_EXAMINED_HE_COUNT"},{"attr_val":"YES","sample":"TCGA-OR-A5LN-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"6","sample":"TCGA-OR-A5LN-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Present","sample":"TCGA-OR-A5LN-01","attr_id":"MITOTIC_RATE"},{"attr_val":"NO","sample":"TCGA-OR-A5LN-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5LN-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5LN-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5LN-01","attr_id":"OS_STATUS"},{"attr_val":"56CDBBA2-327E-4ACD-A1EB-0F313A77834F","sample":"TCGA-OR-A5LN-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"92EE5592-2CEC-4F7C-BF7B-A0A2CEE5E169","sample":"TCGA-OR-A5LN-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5LN-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5LN-01","attr_id":"PATH_T_STAGE"},{"attr_val":"NO","sample":"TCGA-OR-A5LN-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OR-A5LN-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5LN-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5LN-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OR-A5LN-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5LN-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5LN-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5LN-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5LN-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Complete Remission\/Response","sample":"TCGA-OR-A5LN-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5LN-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5LN-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5LN-01","attr_id":"VITAL_STATUS"},{"attr_val":"53","sample":"TCGA-OU-A5PI-01","attr_id":"AGE"},{"attr_val":"Stage IV","sample":"TCGA-OU-A5PI-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Absent","sample":"TCGA-OU-A5PI-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M1","sample":"TCGA-OU-A5PI-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OU-A5PI-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Absent","sample":"TCGA-OU-A5PI-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"709","sample":"TCGA-OU-A5PI-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-19492","sample":"TCGA-OU-A5PI-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OU-A5PI-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OU-A5PI-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OU-A5PI-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Absent","sample":"TCGA-OU-A5PI-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"NOT HISPANIC OR LATINO","sample":"TCGA-OU-A5PI-01","attr_id":"ETHNICITY"},{"attr_val":"2013-7-16","sample":"TCGA-OU-A5PI-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OU-A5PI-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-OU-A5PI-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"None","sample":"TCGA-OU-A5PI-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"No","sample":"TCGA-OU-A5PI-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OU-A5PI-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OU-A5PI-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OU-A5PI-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OU-A5PI-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OU-A5PI-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2011","sample":"TCGA-OU-A5PI-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"160","sample":"TCGA-OU-A5PI-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OU-A5PI-01","attr_id":"LATERALITY"},{"attr_val":"3","sample":"TCGA-OU-A5PI-01","attr_id":"LYMPH_NODES_EXAMINED"},{"attr_val":"3","sample":"TCGA-OU-A5PI-01","attr_id":"LYMPH_NODES_EXAMINED_HE_COUNT"},{"attr_val":"YES","sample":"TCGA-OU-A5PI-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"Mitotic Rate > 5\/50 HPF Absent","sample":"TCGA-OU-A5PI-01","attr_id":"MITOTIC_RATE"},{"attr_val":"YES","sample":"TCGA-OU-A5PI-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Absent","sample":"TCGA-OU-A5PI-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OU-A5PI-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OU-A5PI-01","attr_id":"OS_STATUS"},{"attr_val":"A5BE4E42-CB6C-4E67-8547-45DBD058BB95","sample":"TCGA-OU-A5PI-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"2AA8FA9B-A202-48AB-A543-6E0B1B45B1D4","sample":"TCGA-OU-A5PI-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N1","sample":"TCGA-OU-A5PI-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OU-A5PI-01","attr_id":"PATH_T_STAGE"},{"attr_val":"YES","sample":"TCGA-OU-A5PI-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OU-A5PI-01","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-OU-A5PI-01","attr_id":"PHARM_TX_MITOTANE_FOR_MACRO_DISEASE"},{"attr_val":"YES","sample":"TCGA-OU-A5PI-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"[Unknown]","sample":"TCGA-OU-A5PI-01","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"attr_val":"NO","sample":"TCGA-OU-A5PI-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OU-A5PI-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-OU-A5PI-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-OU-A5PI-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OU-A5PI-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OU","sample":"TCGA-OU-A5PI-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Stable Disease","sample":"TCGA-OU-A5PI-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"WITH TUMOR","sample":"TCGA-OU-A5PI-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OU-A5PI-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OU-A5PI-01","attr_id":"VITAL_STATUS"},{"attr_val":"42","sample":"TCGA-PK-A5H8-01","attr_id":"AGE"},{"attr_val":"YES","sample":"TCGA-PK-A5H8-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"3240","sample":"TCGA-PK-A5H8-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-15373","sample":"TCGA-PK-A5H8-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-PK-A5H8-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-PK-A5H8-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-PK-A5H8-01","attr_id":"DFS_STATUS"},{"attr_val":"NOT HISPANIC OR LATINO","sample":"TCGA-PK-A5H8-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-16","sample":"TCGA-PK-A5H8-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"MALE","sample":"TCGA-PK-A5H8-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-PK-A5H8-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"No","sample":"TCGA-PK-A5H8-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-PK-A5H8-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-PK-A5H8-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-PK-A5H8-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-PK-A5H8-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-PK-A5H8-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2004","sample":"TCGA-PK-A5H8-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"210","sample":"TCGA-PK-A5H8-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-PK-A5H8-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-PK-A5H8-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"NO","sample":"TCGA-PK-A5H8-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"NA","sample":"TCGA-PK-A5H8-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-PK-A5H8-01","attr_id":"OS_STATUS"},{"attr_val":"42EF34CC-FFB4-432C-82BB-7AA56639FF51","sample":"TCGA-PK-A5H8-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"706EC715-C6CD-49A9-8993-D6E5B20AED95","sample":"TCGA-PK-A5H8-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"NO","sample":"TCGA-PK-A5H8-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-PK-A5H8-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-PK-A5H8-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-PK-A5H8-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-PK-A5H8-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-PK-A5H8-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"PK","sample":"TCGA-PK-A5H8-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"TUMOR FREE","sample":"TCGA-PK-A5H8-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-PK-A5H8-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-PK-A5H8-01","attr_id":"VITAL_STATUS"},{"attr_val":"27","sample":"TCGA-PK-A5H9-01","attr_id":"AGE"},{"attr_val":"YES","sample":"TCGA-PK-A5H9-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"307","sample":"TCGA-PK-A5H9-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-10173","sample":"TCGA-PK-A5H9-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-PK-A5H9-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-PK-A5H9-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-PK-A5H9-01","attr_id":"DFS_STATUS"},{"attr_val":"NOT HISPANIC OR LATINO","sample":"TCGA-PK-A5H9-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-16","sample":"TCGA-PK-A5H9-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-PK-A5H9-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-PK-A5H9-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"No","sample":"TCGA-PK-A5H9-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-PK-A5H9-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-PK-A5H9-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-PK-A5H9-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-PK-A5H9-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-PK-A5H9-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2012","sample":"TCGA-PK-A5H9-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"90","sample":"TCGA-PK-A5H9-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Right","sample":"TCGA-PK-A5H9-01","attr_id":"LATERALITY"},{"attr_val":"NO","sample":"TCGA-PK-A5H9-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"NA","sample":"TCGA-PK-A5H9-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-PK-A5H9-01","attr_id":"OS_STATUS"},{"attr_val":"83E7B9F8-04A4-440F-AAFC-7A8E9DDFF284","sample":"TCGA-PK-A5H9-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"A323FD5A-1C3E-49D3-A7EA-04E3663D6883","sample":"TCGA-PK-A5H9-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"NO","sample":"TCGA-PK-A5H9-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-PK-A5H9-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-PK-A5H9-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"ASIAN","sample":"TCGA-PK-A5H9-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-PK-A5H9-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-PK-A5H9-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-PK-A5H9-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"PK","sample":"TCGA-PK-A5H9-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"TUMOR FREE","sample":"TCGA-PK-A5H9-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-PK-A5H9-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-PK-A5H9-01","attr_id":"VITAL_STATUS"},{"attr_val":"63","sample":"TCGA-PK-A5HA-01","attr_id":"AGE"},{"attr_val":"YES","sample":"TCGA-PK-A5HA-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"830","sample":"TCGA-PK-A5HA-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-23345","sample":"TCGA-PK-A5HA-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-PK-A5HA-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-PK-A5HA-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-PK-A5HA-01","attr_id":"DFS_STATUS"},{"attr_val":"[Unknown]","sample":"TCGA-PK-A5HA-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-16","sample":"TCGA-PK-A5HA-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"MALE","sample":"TCGA-PK-A5HA-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-PK-A5HA-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"No","sample":"TCGA-PK-A5HA-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-PK-A5HA-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-PK-A5HA-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-PK-A5HA-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-PK-A5HA-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-PK-A5HA-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2011","sample":"TCGA-PK-A5HA-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"130","sample":"TCGA-PK-A5HA-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-PK-A5HA-01","attr_id":"LATERALITY"},{"attr_val":"1","sample":"TCGA-PK-A5HA-01","attr_id":"LYMPH_NODES_EXAMINED"},{"attr_val":"YES","sample":"TCGA-PK-A5HA-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"NO","sample":"TCGA-PK-A5HA-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"NA","sample":"TCGA-PK-A5HA-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-PK-A5HA-01","attr_id":"OS_STATUS"},{"attr_val":"5EB5EE1F-ECFF-4427-B717-B91380C043AE","sample":"TCGA-PK-A5HA-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"B98EC873-CB6D-4395-A473-C46EC4D2DB00","sample":"TCGA-PK-A5HA-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-PK-A5HA-01","attr_id":"PATH_N_STAGE"},{"attr_val":"NO","sample":"TCGA-PK-A5HA-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-PK-A5HA-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-PK-A5HA-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"[Unknown]","sample":"TCGA-PK-A5HA-01","attr_id":"RACE"},{"attr_val":"NO","sample":"TCGA-PK-A5HA-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-PK-A5HA-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-PK-A5HA-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"PK","sample":"TCGA-PK-A5HA-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"TUMOR FREE","sample":"TCGA-PK-A5HA-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-PK-A5HA-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-PK-A5HA-01","attr_id":"VITAL_STATUS"},{"attr_val":"63","sample":"TCGA-PK-A5HB-01","attr_id":"AGE"},{"attr_val":"1293","sample":"TCGA-PK-A5HB-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-23293","sample":"TCGA-PK-A5HB-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-PK-A5HB-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-PK-A5HB-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-PK-A5HB-01","attr_id":"DFS_STATUS"},{"attr_val":"[Unknown]","sample":"TCGA-PK-A5HB-01","attr_id":"ETHNICITY"},{"attr_val":"2013-9-16","sample":"TCGA-PK-A5HB-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"MALE","sample":"TCGA-PK-A5HB-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical carcinoma- Usual Type","sample":"TCGA-PK-A5HB-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"No","sample":"TCGA-PK-A5HB-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"Yes","sample":"TCGA-PK-A5HB-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-PK-A5HB-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-PK-A5HB-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-PK-A5HB-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-PK-A5HB-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2003","sample":"TCGA-PK-A5HB-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"70","sample":"TCGA-PK-A5HB-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-PK-A5HB-01","attr_id":"LATERALITY"},{"attr_val":"2","sample":"TCGA-PK-A5HB-01","attr_id":"LYMPH_NODES_EXAMINED"},{"attr_val":"YES","sample":"TCGA-PK-A5HB-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"YES","sample":"TCGA-PK-A5HB-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"NA","sample":"TCGA-PK-A5HB-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-PK-A5HB-01","attr_id":"OS_STATUS"},{"attr_val":"9A8EA017-0152-48B2-ACCB-D040DEB1C6B6","sample":"TCGA-PK-A5HB-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"5C732114-DD55-41D6-84C1-9BEDB7DF4345","sample":"TCGA-PK-A5HB-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"YES","sample":"TCGA-PK-A5HB-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"NO","sample":"TCGA-PK-A5HB-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-PK-A5HB-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"[Unknown]","sample":"TCGA-PK-A5HB-01","attr_id":"RACE"},{"attr_val":"YES","sample":"TCGA-PK-A5HB-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"YES","sample":"TCGA-PK-A5HB-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-PK-A5HB-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"PK","sample":"TCGA-PK-A5HB-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"WITH TUMOR","sample":"TCGA-PK-A5HB-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-PK-A5HB-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-PK-A5HB-01","attr_id":"VITAL_STATUS"},{"attr_val":"32","sample":"TCGA-OR-A5JH-01","attr_id":"AGE"},{"attr_val":"Stage II","sample":"TCGA-OR-A5JH-01","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"attr_val":"Atypical Mitotic Figures Absent","sample":"TCGA-OR-A5JH-01","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"attr_val":"M0","sample":"TCGA-OR-A5JH-01","attr_id":"CLIN_M_STAGE"},{"attr_val":"YES","sample":"TCGA-OR-A5JH-01","attr_id":"CT_SCAN_PREOP_RESULTS"},{"attr_val":"Cytoplasm presence <= 25% Present","sample":"TCGA-OR-A5JH-01","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"attr_val":"1227","sample":"TCGA-OR-A5JH-01","attr_id":"DAYS_LAST_FOLLOWUP"},{"attr_val":"-11994","sample":"TCGA-OR-A5JH-01","attr_id":"DAYS_TO_BIRTH"},{"attr_val":"0","sample":"TCGA-OR-A5JH-01","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"attr_val":"NA","sample":"TCGA-OR-A5JH-01","attr_id":"DFS_MONTHS"},{"attr_val":"DiseaseFree","sample":"TCGA-OR-A5JH-01","attr_id":"DFS_STATUS"},{"attr_val":"Diffuse Architecture Present","sample":"TCGA-OR-A5JH-01","attr_id":"DIFFUSE_ARCHITECTURE"},{"attr_val":"[Not Evaluated]","sample":"TCGA-OR-A5JH-01","attr_id":"ETHNICITY"},{"attr_val":"2014-2-6","sample":"TCGA-OR-A5JH-01","attr_id":"FORM_COMPLETION_DATE"},{"attr_val":"FEMALE","sample":"TCGA-OR-A5JH-01","attr_id":"GENDER"},{"attr_val":"Adrenocortical Carcinoma- Oncocytic Type","sample":"TCGA-OR-A5JH-01","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"attr_val":"None","sample":"TCGA-OR-A5JH-01","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"attr_val":"No","sample":"TCGA-OR-A5JH-01","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"attr_val":"No","sample":"TCGA-OR-A5JH-01","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JH-01","attr_id":"ICD_10"},{"attr_val":"8370\/3","sample":"TCGA-OR-A5JH-01","attr_id":"ICD_O_3_HISTOLOGY"},{"attr_val":"C74.0","sample":"TCGA-OR-A5JH-01","attr_id":"ICD_O_3_SITE"},{"attr_val":"YES","sample":"TCGA-OR-A5JH-01","attr_id":"INFORMED_CONSENT_VERIFIED"},{"attr_val":"2008","sample":"TCGA-OR-A5JH-01","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"attr_val":"20","sample":"TCGA-OR-A5JH-01","attr_id":"INITIAL_WEIGHT"},{"attr_val":"Left","sample":"TCGA-OR-A5JH-01","attr_id":"LATERALITY"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JH-01","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"attr_val":"1","sample":"TCGA-OR-A5JH-01","attr_id":"MITOSES_PER_50_HPF"},{"attr_val":"Mitotic Rate > 5\/50 HPF Absent","sample":"TCGA-OR-A5JH-01","attr_id":"MITOTIC_RATE"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JH-01","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"attr_val":"Nuclear Grade III or IV Present","sample":"TCGA-OR-A5JH-01","attr_id":"NUCLEAR_GRADE_III_IV"},{"attr_val":"NA","sample":"TCGA-OR-A5JH-01","attr_id":"OS_MONTHS"},{"attr_val":"LIVING","sample":"TCGA-OR-A5JH-01","attr_id":"OS_STATUS"},{"attr_val":"4F845FEA-E823-47D6-89FB-36EE478A43B8","sample":"TCGA-OR-A5JH-01","attr_id":"OTHER_PATIENT_ID"},{"attr_val":"CF498A30-11FC-4F20-A424-E3A1216D54B2","sample":"TCGA-OR-A5JH-01","attr_id":"PATHOLOGY_REPORT_UUID"},{"attr_val":"N0","sample":"TCGA-OR-A5JH-01","attr_id":"PATH_N_STAGE"},{"attr_val":"T2","sample":"TCGA-OR-A5JH-01","attr_id":"PATH_T_STAGE"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JH-01","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JH-01","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"attr_val":"NO","sample":"TCGA-OR-A5JH-01","attr_id":"PROSPECTIVE_COLLECTION"},{"attr_val":"WHITE","sample":"TCGA-OR-A5JH-01","attr_id":"RACE"},{"attr_val":"[Unknown]","sample":"TCGA-OR-A5JH-01","attr_id":"RADIATION_TREATMENT_ADJUVANT"},{"attr_val":"R0","sample":"TCGA-OR-A5JH-01","attr_id":"RESIDUAL_TUMOR"},{"attr_val":"YES","sample":"TCGA-OR-A5JH-01","attr_id":"RETROSPECTIVE_COLLECTION"},{"attr_val":"01","sample":"TCGA-OR-A5JH-01","attr_id":"SAMPLE_TYPE_ID"},{"attr_val":"OR","sample":"TCGA-OR-A5JH-01","attr_id":"TISSUE_SOURCE_SITE"},{"attr_val":"Complete Remission\/Response","sample":"TCGA-OR-A5JH-01","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"attr_val":"TUMOR FREE","sample":"TCGA-OR-A5JH-01","attr_id":"TUMOR_STATUS"},{"attr_val":"A","sample":"TCGA-OR-A5JH-01","attr_id":"VIAL_NUMBER"},{"attr_val":"Alive","sample":"TCGA-OR-A5JH-01","attr_id":"VITAL_STATUS"}],"attributes":[{"datatype":"STRING","description":"Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","display_name":"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","attr_id":"CLIN_M_STAGE"},{"datatype":"STRING","description":"Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","display_name":"Neoadjuvant Therapy Type Administered Prior To Resection Text","attr_id":"HISTORY_NEOADJUVANT_TRTYN"},{"datatype":"STRING","description":"Oct embedded","display_name":"Oct embedded","attr_id":"OCT_EMBEDDED"},{"datatype":"STRING","description":"The text for reporting information about ethnicity.","display_name":"Ethnicity Category","attr_id":"ETHNICITY"},{"datatype":"STRING","description":"Indicator to signify whether or not whether the patient had adjuvant\/post-operative pharmaceutical therapy.","display_name":"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","attr_id":"PHARMACEUTICAL_TX_ADJUVANT"},{"datatype":"STRING","description":"Atypical Mitotic Figures","display_name":"Atypical Mitotic Figures","attr_id":"ATYPICAL_MITOTIC_FIGURES"},{"datatype":"STRING","description":"Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","display_name":"Tissue Retrospective Collection Indicator","attr_id":"RETROSPECTIVE_COLLECTION"},{"datatype":"STRING","description":"Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","display_name":"Neoplasm Histologic Type Name","attr_id":"HISTOLOGICAL_DIAGNOSIS"},{"datatype":"STRING","description":"Diagnostic ct result outcome","display_name":"Ct scan preop results","attr_id":"CT_SCAN_PREOP_RESULTS"},{"datatype":"NUMBER","description":"Age at which a condition or disease was first diagnosed.","display_name":"Diagnosis Age","attr_id":"AGE"},{"datatype":"STRING","description":"Text terms to describe the status of a tissue margin following surgical resection.","display_name":"Surgical Margin Resection Status","attr_id":"RESIDUAL_TUMOR"},{"datatype":"STRING","description":"The state or condition of an individual's neoplasm at a particular point in time.","display_name":"Person Neoplasm Status","attr_id":"TUMOR_STATUS"},{"datatype":"STRING","description":"The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","display_name":"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","attr_id":"ICD_O_3_HISTOLOGY"},{"datatype":"NUMBER","description":"Overall survival in months since initial diagonosis.","display_name":"Overall Survival (Months)","attr_id":"OS_MONTHS"},{"datatype":"STRING","description":"Therapeutic Mitotane Lvl Progression","display_name":"Therapeutic Mitotane lvl progression","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_PROG"},{"datatype":"STRING","description":"Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","display_name":"American Joint Committee on Cancer Tumor Stage Code","attr_id":"PATH_T_STAGE"},{"datatype":"NUMBER","description":"Days to sample collection.","display_name":"Days to Sample Collection.","attr_id":"DAYS_TO_COLLECTION"},{"datatype":"STRING","description":"Yes\/No\/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","display_name":"New Neoplasm Event Post Initial Therapy Indicator","attr_id":"NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT"},{"datatype":"STRING","description":"Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","display_name":"Tissue Prospective Collection Indicator","attr_id":"PROSPECTIVE_COLLECTION"},{"datatype":"STRING","description":"Form completion date","display_name":"Form completion date","attr_id":"FORM_COMPLETION_DATE"},{"datatype":"STRING","description":"the yes\/no\/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","display_name":"Primary Lymph Node Presentation Assessment Ind-3","attr_id":"LYMPH_NODES_EXAMINED"},{"datatype":"STRING","description":"Patient gender.","display_name":"Person Gender","attr_id":"GENDER"},{"datatype":"STRING","description":"Therapeutic Mitotane Lvl Recurrence","display_name":"Therapeutic Mitotane lvl recurrence","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_AT_REC"},{"datatype":"STRING","description":"The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","display_name":"Neoplasm Disease Stage American Joint Committee on Cancer Code","attr_id":"AJCC_PATHOLOGIC_TUMOR_STAGE"},{"datatype":"STRING","description":"10th revision of the International Statistical Classification of Diseases and Related Health Problems.","display_name":"ICD-10 Classification","attr_id":"ICD_10"},{"datatype":"STRING","description":"Legacy DMP patient identifier (DMPnnnn)","display_name":"Other Patient ID","attr_id":"OTHER_PATIENT_ID"},{"datatype":"STRING","description":"Mitotane Therapy Adjuvant Setting","display_name":"Mitotane Therapy adjuvant setting","attr_id":"PHARM_TX_MITOTANE_ADJUVANT"},{"datatype":"STRING","description":"Cytoplasm Presence Less Than Equal 25 Percent","display_name":"Cytoplasm Presence Less Than Equal 25 Percent","attr_id":"CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT"},{"datatype":"STRING","description":"Excess Adrenal Hormone History Type","display_name":"Excess Adrenal Hormone History Type","attr_id":"HISTORY_ADRENAL_HORMONE_EXCESS"},{"datatype":"NUMBER","description":"Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.","display_name":"Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count","attr_id":"LYMPH_NODES_EXAMINED_HE_COUNT"},{"datatype":"STRING","description":"Vial number","display_name":"Vial number","attr_id":"VIAL_NUMBER"},{"datatype":"STRING","description":"For tumors in paired organs, designates the side on which the cancer originates.","display_name":"Primary Tumor Laterality","attr_id":"LATERALITY"},{"datatype":"STRING","description":"The survival state of the person.","display_name":"Patient's Vital Status","attr_id":"VITAL_STATUS"},{"datatype":"NUMBER","description":"Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","display_name":"Year Cancer Initial Diagnosis","attr_id":"INITIAL_PATHOLOGIC_DX_YEAR"},{"datatype":"STRING","description":"The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","display_name":"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","attr_id":"PATH_N_STAGE"},{"datatype":"STRING","description":"Excess Adrenal Hormone Diagnosis Method Type","display_name":"Excess Adrenal Hormone Diagnosis Method Type","attr_id":"HISTORY_BASIS_ADRENAL_HORMONE_DX"},{"datatype":"STRING","description":"The type of sample (i.e., normal, primary, met, recurrence).","display_name":"Sample Type","attr_id":"SAMPLE_TYPE"},{"datatype":"NUMBER","description":"Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","display_name":"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","attr_id":"DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS"},{"datatype":"STRING","description":"The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","display_name":"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","attr_id":"ICD_O_3_SITE"},{"datatype":"NUMBER","description":"Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","display_name":"Death from Initial Pathologic Diagnosis Date","attr_id":"DAYS_TO_DEATH"},{"datatype":"STRING","description":"Overall patient survival status.","display_name":"Overall Survival Status","attr_id":"OS_STATUS"},{"datatype":"STRING","description":"If the sample is from FFPE","display_name":"Is FFPE","attr_id":"IS_FFPE"},{"datatype":"STRING","description":"Pathology report uuid","display_name":"Pathology report uuid","attr_id":"PATHOLOGY_REPORT_UUID"},{"datatype":"STRING","description":"The text for reporting information about race.","display_name":"Race Category","attr_id":"RACE"},{"datatype":"STRING","description":"A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","display_name":"Tissue Source Site","attr_id":"TISSUE_SOURCE_SITE"},{"datatype":"STRING","description":"Disease free status since initial treatment.","display_name":"Disease Free Status","attr_id":"DFS_STATUS"},{"datatype":"NUMBER","description":"The total number of lymph nodes removed and pathologically assessed for disease.","display_name":"Lymph Node(s) Examined Number","attr_id":"LYMPH_NODE_EXAMINED_COUNT"},{"datatype":"NUMBER","description":"Disease free (months) since initial treatment.","display_name":"Disease Free (Months)","attr_id":"DFS_MONTHS"},{"datatype":"STRING","description":"Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","display_name":"Primary Therapy Outcome Success Type","attr_id":"TREATMENT_OUTCOME_FIRST_COURSE"},{"datatype":"STRING","description":"Therapeutic Mitotane Lvl Macroscopic Residual","display_name":"Therapeutic Mitotane lvl macroscopic residual","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_MACRO"},{"datatype":"STRING","description":"Nuclear Grade III IV","display_name":"Nuclear Grade III IV","attr_id":"NUCLEAR_GRADE_III_IV"},{"datatype":"NUMBER","description":"Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","display_name":"Last Communication Contact from Initial Pathologic Diagnosis Date","attr_id":"DAYS_LAST_FOLLOWUP"},{"datatype":"NUMBER","description":"Weight measured in kilograms.","display_name":"Initial Patient Weight","attr_id":"INITIAL_WEIGHT"},{"datatype":"STRING","description":"Diffuse Architecture","display_name":"Diffuse Architecture","attr_id":"DIFFUSE_ARCHITECTURE"},{"datatype":"STRING","description":"Legacy DMP sample identifier (DMPnnnn)","display_name":"Other Sample ID","attr_id":"OTHER_SAMPLE_ID"},{"datatype":"STRING","description":"Informed consent verified","display_name":"Informed consent verified","attr_id":"INFORMED_CONSENT_VERIFIED"},{"datatype":"NUMBER","description":"Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","display_name":"Birth from Initial Pathologic Diagnosis Date","attr_id":"DAYS_TO_BIRTH"},{"datatype":"STRING","description":"Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","display_name":"Prior Cancer Diagnosis Occurence","attr_id":"HISTORY_OTHER_MALIGNANCY"},{"datatype":"STRING","description":"Sample type id","display_name":"Sample type id","attr_id":"SAMPLE_TYPE_ID"},{"datatype":"NUMBER","description":"Mitoses Count","display_name":"Mitoses Count","attr_id":"MITOSES_PER_50_HPF"},{"datatype":"STRING","description":"Mitotane Therapy For Macroscopic Residual Disease","display_name":"Mitotane Therapy for macroscopic residual disease","attr_id":"PHARM_TX_MITOTANE_FOR_MACRO_DISEASE"},{"datatype":"STRING","description":"Mitotic Rate","display_name":"Mitotic Rate","attr_id":"MITOTIC_RATE"},{"datatype":"STRING","description":"Mitotane Therapy","display_name":"Mitotane Therapy","attr_id":"PHARM_TX_MITOTANE_INDICATOR"},{"datatype":"STRING","description":"Therapeutic Mitotane Levels Achieved","display_name":"Therapeutic Mitotane levels achieved","attr_id":"PHARM_TX_MITOTANE_THERAPUTIC_LEVELS"},{"datatype":"STRING","description":"A yes\/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","display_name":"Did patient start adjuvant postoperative radiotherapy?","attr_id":"RADIATION_TREATMENT_ADJUVANT"}]}
